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ABSTRACT	OF	THE	DISSERTATION	
	
Exploring	the	Regulatory	Role	of	Major	Yeast	Histone	Acetyltransferase	Gcn5	in	pre-mRNA	
Splicing	Genome-wide	
	
by	
	
Shawntel	Udoka	Okonkwo	
Doctor	of	Philosophy	in	Molecular	Biology	
University	of	California,	Los	Angeles,	2020	
Professor	Gregory	Payne,	Chair	
	
The	step-wise	assembly	of	the	spliceosome	onto	pre-mRNA	occurs	co-transcriptionally,	while	
the	nascent	transcript	is	synthesized	from	RNA	Polymerase	II.	The	mechanisms	underlying	the	
molecular	coupling	and	coordination	of	these	co-transcriptional	reactions	have	not	been	
thoroughly	elucidated	in	the	context	of	the	dynamic	chromatin	environment.	The	Johnson	Lab	
previously	discovered	that	the	major	yeast	histone	acetyltransferase	(HAT)	Gcn5	demonstrates	
genetic	interactions	with	MSL1	and	LEA1—which	encode	two	core	U2	small	nuclear	
ribonucleoprotein	particle	(snRNP)	components	of	the	spliceosome.	Additionally,	the	lab	
observed	that	Gcn5	HAT	activity	is	required	for	proper	co-transcriptional	recruitment	of	the	
spliceosome	in	yeast	where	U2	snRNP	association	with	the	pre-mRNA	and	subsequent	
spliceosomal	rearrangements	are	sensitive	to	Gcn5-dependent	acetylation.	While	Gcn5-
 iii 
dependent	histone	acetylation	is	important	for	the	fate	of	spliceosomal	rearrangements	of	
these	two	proteins,	the	genome-wide	implications	and	overall	mechanism	underlying	this	result	
is	not	yet	clear.	Here,	I	employed	RNA-seq	in	S.	cerevisiae	to	identify	mechanistic	insights	into	
how	Gcn5-dependent	histone	acetylation	can	affect	pre-mRNA	splicing.	I	prepared	libraries	
from	the	following	yeast	strains:	wildtype,	gcn5Δ	and	H3Δ9-16	(deletion	of	residues	9-16	from	
histone	H3	N-terminal	tail)	such	that	genes	for	which	splicing	is	similarly	affected	in	both	gcn5Δ	
and	H3Δ9-16	will	represent	a	defect	specific	to	the	absence	of	Gcn5-histone	acetyltransferase	
(HAT)	activity.	Surprisingly,	the	results	support	a	role	for	the	Gcn5-HAT	in	decreasing	gene	
expression	of	all	intron-containing	ribosomal	protein	genes	(IC-RPGs).	Consequently,	gcn5Δ	and	
H3Δ9-16	improved	the	splicing	efficiency	of	a	subset	of	IC-non-RPGs	in	a	manner	regulated	by	
the	competition	of	IC-RPGs	for	limited	spliceosomes.	Lastly,	gcn5Δ	and	H3Δ9-16	resulted	in	the	
decreased	splicing	efficiency	for	another	subset	of	IC-non-RPGs.	With	publicly	available	ChIP-
seq	and	MNase-seq	data,	I	show	that	despite	the	increased	availability	of	limited	spliceosomes	
via	down-regulation	of	IC-RPGs,	gcn5Δ	and	H3Δ9-16	dependent	splicing	outcomes	of	IC-non-
RPGs	are	distinguished	by	differences	in	RNAPII,	H3K9ac	and	MNase	enrichment	profiles.	In	this	
thesis,	I	uncover	multiple	effects	of	the	gcn5Δ	and	H3Δ9-16	on	pre-mRNA	splicing	genome-
wide--encompassing	mechanisms	regarding	the	economics	of	limited	spliceosome	availability	
and	distinct	chromatin	landscapes	directly	regulating	splicing	outcomes.		
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CHAPTER 1 - Introduction 
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 1.1 Introduction to gene regulation 
Biological definitions of life often rest upon the understanding that an organism arose from a 
set of instructions encoded in molecules and the biochemical reactions that drive them. 
Deoxyribonucleic Acid (or DNA for short), is the molecule that sets the biological foundation for 
not only what initiates life, but allows it to persist and thrive. On a macro-scale, it is accepted 
that our interstellar universe is predicated on entropic reactions and there is a level of 
regulation that produces the meta-level balance we understand to be today. On a micro-scale, 
the parallel argument remains as our molecular universe is overwhelmingly complex, diverse, 
dynamic and requires regulation for balance and harmonious production. 
 
The instructions present in DNA molecules are called genes. Genes are the units of DNA 
molecules that provide the instructions for life. The central dogma of molecular biology posits 
that the genes present in the DNA starting material are replicated for effective scale (DNA 
replication), then are transcribed to produce the necessary working material for carrying out 
these instructions (RNA transcription) followed by the penultimate step of producing the 
protein workhorses that sustain cellular activity (protein translation). Although seemingly 
straightforward, since inception, this dogmatic view of biology has been expanded to include 
the wide-reaching nuances that further define and elucidate how life works at this molecular 
level. There are also spatio-temporal contexts to consider when discussing the implications of 
the central dogma of molecular biology. Developmental biology over time, homeostasis and the 
balance for sustained life and health of the cell/organism that can productively respond to 
internal/external stress, changes in environment, aging and any other reactionary/proactive 
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 needs. Additionally keeping in mind the sheer magnitude of the tasks required to give rise to 
and maintain a living organism for the duration of a lifetime, one must consider the amount of 
entropy, randomness and chaos that can potentially exist as a result. This in particular is one of 
the primary reasons why gene regulation emerged as a field—to study how and why organisms 
are able to, in an organized and systematic manner, sustain life despite a molecular genetic 
landscape that is complex, deeply interconnected and primed for chaos and disorder. 
 
Over the past few decades, our understanding of the regulation of gene expression has 
evolved. Until recent decades, the linear understanding of the central dogma of molecular 
biology drove sentiments around genes either being activated or repressed. Activation of genes 
was understood to be the functional precursor to the final gene product (the associated 
protein’s structure and function in the cell) and for repression of genes, vice versa. We now 
understand that this seemingly unilateral biological process is highly ordered and involves an 
intricate series of events that give rise to complex outcomes at the extra-/intra-cellular and 
molecular level. There are numerous steps in gene regulation and many of these modes often 
participate in highly orchestrated cross-regulation--such as RNA transcription and processing. 
 
1.2 Introduction to RNA transcription and co-transcriptional RNA processing 
The immediately functional product of DNA is the ribonucleic acid (RNA) molecule. Although 
the main structural difference between DNA and RNA is the presence of a hydroxyl group on 
the 2’ carbon instead of a hydrogen group, the functional differences vary considerably. RNA is 
produced by biochemical reactions orchestrated by an RNA polymerase enzyme with DNA as 
3 
 the template and reaction substrate. In eukaryotic organisms, the RNA Polymerase II (RNAPII) 
holoenzyme is the protein responsible for transcribing messenger RNA from the DNA template. 
Through a series of reactions, RNAPII forms step-dependent complexes with other modular 
proteins throughout the transcription reaction in order to produce nascent mRNA (or 
pre-mRNA).  
 
Pre-mRNA is the native product of RNAPII transcription from the DNA template and as such, 
this nascent molecule must undergo a considerable amount of processing and quality control to 
become mature messenger RNA. This processing is necessary for the messenger RNA to encode 
the proper functional instructions for the destined proteins as well as survive the vulnerable 
transport from the nucleus to the cytoplasmic ribosomes for protein translation. Pre-mRNA 
processing can occur co-transcriptionally--that is simultaneously with the RNA molecule being 
synthesized from RNAPII. For example, the 5’ end of the nascent RNA molecule (specifically, the 
exposed guanosine) is methylated which produces a protective cap structure around the 
exposed end of the RNA. This 5’ 7-methylguanosine cap not only protects the 5’ end of the 
pre-mRNA molecule from degradation by exonucleases, but also functions to promote protein 
translation and regulate nuclear export. The most fascinating aspect of this molecular process is 
that this regulatory process occurs co-transcriptionally--functioning to court and prepare the 
RNA molecule for other modes of gene processing and regulation. In yeast, the enzymes 
associated with 5’ capping of pre-mRNA include guanylyltransferase Ceg1p, methyltransferase 
Abd1p and triphosphatase Cet1p. These factors are recruited to RNAPII and deployed in 
synergy with the C-terminal domain (CTD) phosphorylation states of RNAPII--the transition from 
4 
 transcriptional initiation to elongation--in both yeast and humans (Cho et al., 1998; Ho et al., 
1998; Ho and Shuman, 1999). The regulated association and dissociation of these RNA 
processing factors is in direct synergy with the phosphorylation and dephosphorylation states 
of RNAPII CTD during transcription (Komarnitsky et al., 2000; Schroeder et al., 2000). This is just 
one example of how RNA processing is implicated during gene regulation.  
 
Co-transcriptional gene regulation often occurs in a spatio-temporal manner. The coupling of 
RNAPII transcription and RNA processing events does not occur solely for the 
compartmentalization of molecular time. There is a large body of research that investigates the 
coupling of transcription and pre-mRNA processing. Hypotheses range from general cellular 
resource allocation to high-level quality control to other explanations regarding the economics 
of the cell. While pre-mRNA processing hosts a number of mechanisms for regulation in order 
to give rise to a mature mRNA product primed for protein translation, the primary mode of 
regulation explored here is pre-mRNA splicing. 
 
1.3 The splicing of pre-mRNA is a key mRNA processing and quality control mechanism in 
eukaryotic organisms 
The immediate product of RNAPII transcription is a nascent RNA molecule based on the 
preceding complementary DNA template, which as a result, contains both protein-coding RNA 
sequences (exons) and non-protein-coding sequences (introns). In order for these precursor 
RNA molecules to give rise to functional protein products, they must be further processed into 
mature mRNA molecules and made amenable for ribosomal translation in the cell. This key 
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 quality-control step in mRNA processing is known as pre-mRNA splicing which occurs in the 
nucleus. Introns are removed from nascent RNA molecules and the resulting exonic sequences 
are spliced together, giving rise to mature mRNA (Berget et al., 1977; Chow et al., 1977). 
 
The splicing reaction of pre-mRNA occurs through an array of coordinated biochemical 
mechanisms involving the step-wise assembly of the spliceosome. The spliceosome is a large 
ribonucleoprotein complex consisting of over 100 splicing factors and small nuclear 
ribonucleoproteins (snRNPs) which dynamically interact and rearrange over the splicing 
reaction (Brow, 2002; Matlin and Moore, 2007; Staley and Woolford, 2009). In yeast, each 
intron-containing pre-mRNA transcript contains highly-conserved sequences that are 
specifically recognized by components of the spliceosome during various steps of the splicing 
reaction for sequence binding, catalysis and exon ligation--namely, the donor site (5’ splice site; 
5’ SS), the branchpoint sequence (BPS) and the acceptor (3’ splice site; 3’ SS) (Burge et al., 
1999). In yeast, the typical consensus for both 5’ SS and 3’ SS are defined by dinucleotides ‘GU’ 
and ‘AG’, respectively. However, the branchpoint sequence tends to be defined by a longer 
7-nucleotide notation--UACUAAC. Mutation of and/or lack of consensus in these splice site 
sequences may slightly disrupt or completely inhibit the assembly of the spliceosome onto the 
transcript and therefore the efficiency of the splicing reaction (Weiner and Zhuang, 1986; 
Wimmer et al., 2007). 
 
Although a highly dynamic process involving over 100 proteins and structural rearrangements, 
splicing is generally driven by two transesterification reactions on the pre-mRNA substrate 
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 (Moore et al., 1993). During the first reaction, the bulged 2’ -OH group on the BPS adenosine 
nucleotide performs a nucleophilic attack on the 5’ SS, resulting in intron cleavage (from the 5’ 
end of the transcript) and formation of an intermediate lariat structure (of the intron and 3’ end 
of the transcript). In the second reaction of splicing, the free 3’ -OH group of the 5’ exon attacks 
the 3’ ss to finally ligate the two exon products together.  
 
One important aspect of pre-mRNA splicing is its role in establishing proper protein diversity in 
the organism. In higher eukaryotes such as mammals, most RNA transcripts are alternatively 
spliced to give rise to protein diversity that will subsequently meet a variety of needs for the 
cell.  
 
1.4 Chromatin is a structural and functional regulatory platform for gene regulation 
In Eukaryotes, DNA contains the critical genetic instructions for initiating and maintaining life in 
a living organism. Depending on the Eukaryotic organism, there can be anywhere from 
hundreds to tens of thousands of genes across the genome, and these genes undergo complex 
spatio-temporal conformations in order to regulate gene expression at any given time in 
development. In light of the high order of complexity and spatial constraints to gene regulation 
at the molecular level, physical structure is another dimension by which to regulate gene 
expression.  
 
Fortunately, eukaryotes have evolved to accommodate the growing complexity of the 
three-dimensional genome and all of its dynamicity through space, time and environmental 
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 stimuli. Chromatin is the physical scaffold for nuclear DNA to compress upon itself and is the 
structural combination of DNA, RNA and proteins. Throughout the eukaryotic genome, lengths 
of DNA molecules are wrapped around the macromolecular nucleosome structures, which 
effectively condenses the amount of DNA per unit of space in the nucleus.  
 
Nucleosomes, the fundamental unit of chromatin, wrap approximately 147bp of DNA and are 
highly repeated throughout the genome (Luger et al., 1997). This level of compaction reduces 
the structural burden of encasing enough DNA in the cell nucleus for effective gene expression, 
but also leaves a new problem of chromatin accessibility to gene expression machinery. 
Nucleosomes consist of an octamer of histones, which have expanded beyond straightforward 
structural implications (i.e. chromatin compaction) for gene regulation into functional 
implications.  
 
Histone proteins contain unique structural features that provide a platform for additional gene 
regulation, specifically post-translational modifications at their N-termini. A wide array of 
nuclear enzymes add methyl, acetyl and other chemical groups to the amino acid residues of 
the N-terminal tails of these histones, which in turn biochemically configure the structure of 
chromatin. Two main conformational states of chromatin often referenced are euchromatin 
and heterochromatin--the former referring to loosely bound chromatin and the latter referring 
to tightly bound chromatin. Each physical state has functional implications for gene expression 
as the loose state of DNA wrapped around euchromatin affords accessibility to transcriptional 
machinery. In contrast, heterochromatin is too tightly condensed to allow gene activation to 
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 occur. Certain post-translational modifications of the histone N-terminal tails facilitate these 
chromatin states. For example, histone acetylation is the addition of an acetyl functional group 
from bioavailable Acetyl-CoA to Lysine residues on histone tails. When this enzymatic reaction 
occurs, the positively charged histone tail is neutralized (due to the negative charge of the 
acetyl group). The interaction between negatively charged DNA and the positively charged 
histones is weakened by this acetylation which loosens the interaction of the DNA with the 
nucleosome. Histone acetylation is often associated with gene activation as this biochemical 
reaction produces euchromatin and thus, an accessible environment for transcription factors to 
physically bind to gene promoters and initiate transcription. 
 
2.1 What is co-transcriptional splicing and what is its relevance to gene regulation? 
RNA processing events such as splicing, 5’ capping and polyadenylation have been shown to 
occur simultaneously in concert with the process of transcription whereby the eukaryotic 
C-terminal domain (CTD) of the Rpb1 subunit of RNA Polymerase II holoenzyme (RNAPII) can 
serve as a physical regulatory platform for these processes. The step-wise assembly of the 
spliceosome onto pre-mRNA occurs co-transcriptionally. In addition to ensuring proper 
constitutive splicing for all intron-containing genes, the co-transcriptional nature of the splicing 
machinery facilitates the production of alternative transcripts from the same RNA template. 
Although the co-transcriptional nature of splicing is emerging as a well-researched topic, the 
mechanisms underlying the coupling and coordination of these reactions have not been well 
elucidated. These studies examine the mechanisms by which the highly dynamic chromatin 
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 marks that are placed on histones during transcription affect splicing. They address a looming 
key question: How are these two reactions linked in the cell?  
 
The splicing of pre-mRNA is carried out by the spliceosome, a large multi-subunit 
ribonucleoprotein complex which catalytically facilitates intron removal and exon ligation 
(Figure 1). The spliceosome is a highly dynamic and intricate molecular machine that assembles 
onto pre-mRNA in a stepwise manner. In each step of the splicing reaction, a multitude of 
biochemical conformations and RNA-protein interactions facilitate the recognition of canonical 
sequences within the intron, catalysis of the intronic sequences and ligation of the exon. 
In the first commitment step of splicing, the U1 snRNP combined with other splicing factors 
recognizes the dinucleotide 5’ splice site sequence (GU), which is positioned at the first 2 
nucleotides of intronic RNA (Ruby and Abelson, 1988; Seraphin and Rosbash, 1989; Du and 
Rosbash, 2001). Following this early commitment step, the pre-spliceosome complex is formed 
as U2 snRNP complexed with enzymatic splicing factors recognize and bind to the branchpoint 
sequence (BPS) of the pre-mRNA substrate and expose the branch-point adenosine nucleotide 
for nucleophilic attack (Parker et al., 1987). In subsequent steps, the U4/U6-U5 tri-snRNP, in 
association with other splicing factors, complete the assembly of the spliceosome and further 
carry out the formation of the lariat intermediate, intron excision and exon ligation.  
 
Co-transcriptional splicing is described as the simultaneous assembly of the spliceosome onto 
pre-mRNA while RNA Polymerase II and associated factors transcribe said pre-mRNA molecule 
(Figure 1C). As the 5’ end of the nascent RNA molecule emerges from the exit tunnel of RNAPII, 
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 the 5’SS is immediately recognized by splicing factors and spliceosome assembly begins. Early 
experiments to directly decipher the nature of this functional relationship were performed by 
Chromatin Immunoprecipitation (ChIP), which assays for direct DNA-protein interactions in 
cell-extracts (Gornemann et al., 2005; Lacadie and Rosbash, 2005; Wetterberg et al., 2001). The 
experimental design of ChIP does not accommodate direct interaction of protein with RNA, 
however, given the proximity of splicing components to the DNA template associated with the 
RNA in question, sound observations can be derived (Kotovic et al., 2003). The genome-wide 
observations of splicing-dependent RNAPII pausing events at exons provided robust and 
nuanced evidence to support the co-transcriptional nature of splicing (Carrillo Oesterreich et 
al., 2010; Alexander et al., 2010). 
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Figure 1. Pre-mRNA splicing and spliceosome assembly in yeast​ - A) The splicing of pre-mRNA in eukaryotes 
involves specific sequence-based motifs (5’ splice site (5’ SS), the 3’ SS and the branchpoint sequence (BPS). The 
splicing reaction occurs in two transesterification steps including lariat intermediate formation, catalysis and 
ligation of exons. Exons represented with blue and indigo boxes and introns with black line. B) The differences of 
splice site sequence motifs between yeast and metazoans. C) Spliceosome assembly contains a variety of 
RNA-protein interactions (Adapted from Will and Luhrmann, 2011). 
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 Understanding the intersectional nature of co-transcriptional splicing with other modes of gene 
regulation at the mechanistic level is a field that is justly gaining attention as it begins to answer 
some of the fundamental questions in the splicing field: How and why is splicing linked to 
transcription? What evolutionary and biological purpose does this serve for the cell in a 
unicellular context as well as in the context of higher order organisms which have more 
sophisticated gene regulation programs and highly complex chromatin environments? In the 
context of chromatin, how does the highly dynamic nature of histone acetylation affect and 
correspond to the dynamic rearrangements of spliceosome assembly during transcription? 
Given the dynamic nature of co-transcriptional splicing, the composition of the spliceosome 
may also reflect the spatio-temporal priorities of the spliceosome in the co-transcriptional 
splicing reaction. For example, components of the transcriptional and chromatin environment 
have been shown to physically recruit components of the spliceosome to facilitate the splicing 
reaction (Leung et al., 2019; Luco et al., 2010). 
 
2.2 Influence of chromatin on co-transcriptional splicing in yeast and mammals 
Splicing is co-transcriptional, the transcription program is inherently linked to the chromatin 
environment and studies have shown that different components of the chromatin environment 
can interact with (and regulate) the spliceosome machinery. Given the broad range of 
chromatin modifications to explore, I will focus on histone acetylation and splicing. For 
example, depletion of a histone deacetylase increased H4 acetylation around alternative exonic 
junctions which lead to an increase in RNAPII elongation rate and subsequently decreased 
inclusion of the alternative exon. Gonzalez et al. demonstrated that lncRNA generated from the 
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 human FGFR2 locus can regulate cell-specific alternative splicing through specific chromatin 
signatures (Gonzalez et al., 2015). A more direct relationship can be seen with Mrg15, a 
chromatin binding protein that specifically recognizes H3K36me3 marks and subsequently 
recruits the polypyrimidine-tract binding protein, Ptbp2, to the pre-mRNA 
substrate—facilitating exon-definition and thereby functioning as a direct regulatory link 
between the chromatin environment and the splicing machinery (Iwamori et al., 2016). 
Interestingly, single-gene studies on human genes ​FN1 ​and ​MCL1​ have demonstrated a role for 
histone deacetylation by HDACs in regulating alternative splicing (Hnilicova et al., 2011; Khan et 
al., 2014; Choudhary et al., 2009; Gao and Koide, 2013). Finally, Schor and colleagues observed 
that perturbation of chromatin structure globally affects localization and recruitment of splicing 
factors (Schor et al., 2012). 
 
A growing body of literature supports the role of nucleosomes in pre-mRNA splicing. One of the 
earliest observations of a relationship between splicing-relevant gene architecture and 
nucleosomes was led by Baldi et al., where they found naturally occurring nucleosome 
positioning signals in human exons and introns (Baldi et al., 1996). Here, they showed that 
exons (rather than introns) preferentially inhabit sequence triplets which have a 
thermodynamic preference for “locations on a bent double helix where the major groove faces 
inward and is compressed. The in-phase triplets are located adjacent to GCC/GGC triplets 
known to have the strongest bias in their positioning on the nucleosome.” This observation was 
explored further by Denisov et al. as well as Kogan et al. as they rationalized the functional 
purpose for this sequence pattern to be a protection mechanism for splice sites (Denisov et al., 
14 
 1997; Kogan et al., 2005). Specifically, intronic splice sites on the template DNA strand are 
reported to be positioned near the center of the nucleosome particle for protection from 
UV-irradiation, nucleases and other cellular threats (Gale et al., 1987; Liu et al., 2000; 
Sollner-Webb et al., 1978; Thrall et al., 1994; Anderson and Widom, 2000). Lastly, an intriguing 
observation that single-nucleotide polymorphisms (SNPs) occur less frequently upstream of 
splice sites supports the protective model of nucleosomes to splice sites (Fairbrother et al., 
2004). 
 
With the emergence of sequencing technologies, there is now a substantial wealth of data by 
which research groups no longer need to explore each question from the bench. These 
innovations have inspired a new ethos of collaboration and multidisciplinarity in the scientific 
community, thereby reducing the pressure of time, increasing access to resources/facilities and 
shifting equity in intellectual pursuits between public and private institutions. To this concept, 
research groups over the years have begun analyzing publically available data-sets to answer 
new and hidden questions in a variety of contexts. This lends increased nuance to the variety of 
observations and questions that can be answered about chromatin and splicing in yeast. 
Additional observations on chromatin architecture and splicing have been uncovered through 
groups analyzing publically available data-sets derived by other members of the scientific 
community. Elegant work by Andersson et al. showed that there is a bias in nucleosomal 
positioning over exons as opposed to introns that is also independent of expression level in 
both humans and C. elegans (Andersson et al., 2009). Additionally, this group observed a higher 
incidence of histone modifications (largely H3K36me3, H3K79me1, H2BK5me1, H3K27me1, 
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 H3K27me2, and H3K27me3) encompassing internal exons relative to the tandem intron 
(Andersson et al., 2009). From the Johnson lab, Leung and colleagues most recently uncovered 
a physical recruitment mechanism for the role of H3K36me3 in regulating constitutive splicing. 
This work showed that the chromodomain protein Eaf3 physically links the spliceosome to 
H3K36 methylation (Leung et al., 2019).  
 
Through computational modeling of microarray data, Chen and colleagues observed higher 
occupancy of nucleosomes arranged at exonic sequences whereas intron sequences displayed 
lower occupancy in mammals (Chen et al., 2010). Additionally, by quantifying RNA structural 
flexibility with diversity of folding to energy ratios across transcripts, they observed that 
nucleosome occupied regions (exonic sequences) tend to have more rigid RNA structures while 
nucleosome-depleted regions had the opposite. While earlier groups have explored gene 
architecture within the context of nucleosomes, this data lends additional support for a 
relationship between nucleosome positioning and splice site definition. 
 
Chromatin modifiers and signatures are now being understood to have a complex relationship 
with the splicing machinery. In the past 10 years, the Johnson lab has investigated multiple 
aspects of the relationship between chromatin and splicing. Since both of these features of 
gene regulation are individually complex, the relationships that synergize them are varied, 
nuanced and can be both specific and generalized. Our lab has previously shown that the major 
yeast histone acetyltransferase (HAT) GCN5, has genetic interactions with ​MSL1​ and ​LEA1​—two 
U2 snRNP components of the spliceosome (Gunderson and Johnson, 2009). Additionally, we 
16 
 observed that Gcn5 and its acetylation activity are required for proper co-transcriptional 
recruitment of the spliceosome in yeast (Gunderson et al., 2011). Specifically, U2 snRNP 
association with the branch-point of the pre-mRNA substrate and subsequent spliceosomal 
rearrangements are sensitive to Gcn5-dependent acetylation. Intriguingly, Gcn5-dependent 
acetylation is enriched at the promoter, but the HAT is found throughout the intron-containing 
genes, ​DBP2​ and ​ECM33​. Deletion of histone deacetylases ​HOS2​ and ​HOS3​ reveals H3K9 and 
H3K14 acetylation throughout the gene bodies and abnormal persistence of U2 snRNP factors 
at the branch-point region of the pre-mRNA—with aberrant recruitment of downstream 
splicing factors (Gunderson et al., 2011). 
 
The Johnson Lab demonstrated that Gcn5-dependent acetylation is important for spliceosomal 
rearrangements, however, it is not clear what the mechanism underlying this result is. The 
orchestration between HAT and HDAC activity on the DNA may be important for recruitment of 
factors that bind to chromatin and recruit the spliceosome or for tuning transcription 
elongation rates for proper stepwise recruitment of the spliceosome on the pre-mRNA 
substrate. Here, my thesis seeks to discover mechanistic insights into how Gcn5-mediated 
histone acetylation affects the splicing reaction genome-wide. Here, we seek to discover 
mechanistic insights into how Gcn5-mediated histone acetylation affects the splicing reaction. 
 
2.3 Exploring co-transcriptional splicing in ​Saccharomyces cerevisiae ​as an ideal model 
organism 
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 Addressing questions of co-transcriptional splicing in the model organism, ​Saccharomyces 
cerevisiae​ is ideal as it presents several advantages relevant to this research. Co-transcriptional 
splicing is a complex topic to experimentally investigate as it must account for the nuanced 
aspects and intrinsically dynamic features of transcription elongation, spliceosome assembly 
and the chromatin environment. Budding yeast is an organism that allows for an array of 
genetic and biochemical experimental manipulations to elegantly probe these mechanisms 
both in vivo and in vitro. For example, the genetic system in budding yeast is highly tractable, 
which provides the opportunity to create and combine synthetic mutations to test these 
questions. Additionally, the spliceosome machinery in the budding yeast is highly conserved 
between higher eukaryotes which ensures relevancy. Lastly, unlike the mammalian genome 
where variability of intron length, intron number and alternative splicing events for a single 
gene vary considerably, the genome of the budding yeast is more streamlined as about 5% of all 
genes contain introns (with a vast majority of these genes containing single introns which 
adhere to strong splice site consensus) and alternative splicing is limited. 
 
3.1 The role of Gcn5 in histone acetylation and ribosomal gene regulation 
In eukaryotes, activation of gene expression is regulated by a number of factors that are 
sequential, dynamic and highly regulated. As noted above, post-translational acetylation of 
lysine residues within the N-terminal tail of histone H3 is crucial to gene activation. This 
reaction is facilitated by the catalytic activity of Gcn5, the major yeast histone 
acetyltransferase, and Acetyl-CoA. Gcn5 recognizes and binds to lysine residues, catalyzes the 
transfer of an acetyl group from acetyl-CoA to the epsilon-amino group of lysines and activates 
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 gene expression through histone-associated interactions with DNA (Tanner et al., 2000). The 
mechanism of action for this enzyme “utilizes a conserved glutamate residue to function as a 
general base through a bi-bi ternary complex mechanism (Trievel et al., 1999; Rojas et al., 1999; 
Clements et al., 1999). In this mechanism, both the acetyl-CoA and the substrate protein must 
be bound to the enzymes before catalysis can occur, and the turnover number for Gcn5 (kcat) is 
very efficient at ~210 min−1” (Poux et al., 2002). 
 
While in a hetero-chromatinized (or closed) state, chromatin fibers are tightly wound--making it 
difficult for the pre-initiation complex of RNA-polymerase II to access the DNA for 
transcriptional activation with this type of locus often described as a repressed state, as 
described previously. Upon post-translational modification of the residues in proximity to the 
native DNA, the interaction between the histone proteins and the DNA weaken, thus allowing 
for the pre-initiation complex to assemble at the euchromatin locus and activate gene 
transcription. 
 
Gcn5, a member of the P/CAF family of histone acetyltransferases, is known to acetylate most 
lysines on the N-terminus of histone H3, most notably being Lysine 9, 14, 18, 23 (Yang et al., 
1996).  ​In vivo​, minor acetylation by Gcn5 has been observed on residues 8 and 16 of histone 
H4 and lysine residues in the amino-terminus of histone H2B (Grant et al., 1999; Zhang et al., 
1998). It is suggested that due to the N-/C-terminal ɑ2 and ɑ4 helix residues interacting with 
the backbone of substrates rather than the side chains, Gcn5’s fidelity for both histone and 
non-histone targets is high (Friedmann & Marmorstein, 2013). One of the major non-histone 
19 
 targets of Gcn5 is the transactivator complex regulating ribosomal protein gene (RPG) 
expression. 
 
Other than its role in post-translational histone modification, a number of reports have 
implicated Gcn5 in the regulation of RPG expression. For example, Gcn5 acetylates Ifh1, one of 
the master regulators of RPG expression--which effectively titrates it away from RPG promoters 
and thus aids in transcriptional repression of RPGs during nutrient stress (Downey et al., 2013). 
Additionally, acetylation by Gcn5 at the RPG cis-regulatory element ​URS1​, is essential for 
activation of ​IME2​, Ime1 and RSC, all critical components of the RPG expression program 
(Burgess et al., 2009).  
 
4.1 Gcn5 plays multiple roles in cancer progression, maintenance, gene regulation and gene 
therapy 
Being that Gcn5 is a crucial component of gene activation and chromatin accessibility, it plays a 
number of roles in maintaining cellular and genomic health/stability. Most of the abrogations in 
human health which implicate Gcn5 often associate with the role of the enzyme through 
indirect gene regulation and more direct protein acetylation. Interestingly, it was revealed that 
Gcn5 facilitates histone acetylation, nucleosomal eviction and RNA Polymerase II progression 
particularly at stress genes under stressed conditions in ​S. pombe ​(Sanso et al., 2011). 
 
For example, many groups have reported the role of Gcn5 in cancer--this is separate from the 
additional roles in other non-cancerous human diseases. With c-Myc being heavily 
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 over-expressed in cancer genetics, Gcn5 has been found to target this as a catalytic substrate as 
it stabilizes the protein through acetylation of lysine 323 on c-Myc itself (Flinn et al., 2002 & 
Patel et al., 2004). Additionally, Gcn5 has been found halt cellular differentiation in acute 
lymphoblastic leukemia (ALL) by acetylating and stabilizing the oncoprotein E2A-PBX1 and 
targeting HOX--an important factor in human cellular development (Holmlund et al., 2013 & Lu 
& Kamps, 1997). Gcn5 has also been implicated in breast cancer stem cell progression through 
other crucial human cellular development pathways such as the Wnt/beta-Catenin pathway 
(Chen et al., 2010). Interestingly, Gcn5 also acetylates the well-known tumor suppressor p53 to 
promote activation of its target genes (Barlev et al., 2001). Within breast cancer cells, Gcn5 
more directly acetylates microtubule proteins via oncoproteins which serves a role in 
facilitating cancer cell movement (Li et al., 2015). 
 
Gcn5 plays a major role in regulating genes associated with cancer via its histone acetylation 
activity. In 2016, researchers found that Gcn5 functions in promoting Hepatocellular Carcinoma 
(or liver cancer) progression by regulating and enhancing the expression of AIB1 (Amplified in 
Breast Cancer 1)--an oncogene strongly implicated in liver cancer (Majaz et al., 2016). Another 
role of Gcn5 regulating the gene expression in human disease has been uncovered in 
acetylating H3K9 on E2F1’s promoter which enhances the expression of cell cycle control 
factors Cyclin D1 and Cyclin E--specifically promoting lung cancer progression. Not surprisingly, 
Gcn5 has also proven to be an attractive target for drug inhibitors, as inhibition of its HAT 
activity demonstrated effectiveness in blocking neuroblastoma cell growth (Gajer et al., 2015). 
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 For decades, budding yeast has been used as a model for studying gene expression. Many of 
these studies in yeast aimed at understanding basic biology have uncovered and set the 
foundation for understanding mechanistic aspects of human disease. Through the strategic 
advantage of yeast genetics as a proxy for understanding human disease, many groups have 
successfully uncovered multiple roles for Gcn5 in human disease. 
 
5. Genome-wide approaches for studying gene regulation 
Until about 15 years ago, microarray analysis was the primary method for characterizing effects 
of gene mutation on the expression of a majority of genes. With the advent of next-generation 
sequencing, thoroughly answering sophisticated questions about gene regulation with the fine, 
base-pair resolution was finally possible. By coupling chemical manipulations (via crosslinking, 
nuclease and other chemical methods) to genome-wide surveys, multiple methods for 
understanding the full breadth of genomic features in a variety of mutant backgrounds and 
conditions was attainable. From exploring how the lack of a histone acetyltransferase affects 
gene expression across the genome through metabolic cycles to uncovering novel roles for 
otherwise canonical protein factors--genome-wide sequencing technologies afford deep 
excavation into the structural and functional mysteries of the genome. These methods will be 
explored in more detail as it pertains to Gcn5 in the following sections. 
 
5.1 Types of mutations that elucidate Gcn5-dependent gene regulation genome-wide 
gcn5Δ​ means that ​GCN5​ is genetically mutated and the Gcn5 protein is absent from the cell. 
While gene deletion is a straightforward and classic approach in understanding the functional 
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 role of the gene product, gene deletion can lead to confounding results. Gcn5 is present and 
central to a number of cellular processes--such as histone acetylation, ribosomal protein gene 
regulation, pluripotency and cellular reprogramming as well as stress response. As the 
loss-of-function phenotype is viable, complete lack of Gcn5 in a cell can potentially trigger 
compensatory mechanisms for maintaining cellular stability.  
 
The most conserved portion of Gcn5 is the HAT domain--the bromodomain region of the 
protein that interacts with and acetylates histone substrates (Brownell et al., 1996). This 
catalytic HAT domain spans amino acid residues 99 to 260 (Candau et al., 1997). It has also been 
long established that the substitution mutation, Y413A, in Gcn5 present in the ADA subcomplex 
of SAGA abgrogates acetyl-binding but does not affect the bromodomain or ADA complex 
structure (Syntichaki et al., 2000; Dhalluin et al., 1999; Li and Shogren-Knaak, 2009; Mujtaba et 
al., 2002). 
 
Mutation of the HAT domain of Gcn5 is still in complex with SAGA, but catalytically inactive to 
bind and acetylate histone substrates. This type of mutation is typically utilized when aiming to 
understand the contribution of SAGA in full complex when Gcn5 is unable to acetylate histone 
or non-histone targets. Questions asked of this type of mutation could be whether Gcn5 can 
physically associate with specific target substrates outside of its catalytic role in histone 
acetylation.  
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 Lastly, Gcn5 is known to interact with Ada2 and Ada5 within SAGA and the ADA subcomplex 
(Candau et al., 1997). This interaction facilitates nucleosomal acetylation as Gcn5 on its own 
(out of complex) confers weak acetylation to histone lysine substrates and is only strengthened 
in complex with SAGA as well as in the ADA subcomplex (Sterner et al., 2002; Candau et al., 
1997). Deletion of the Ada2-interacting domain of Gcn5 (Gcn5 residues 260–280; just 
downstream of the HAT domain) results in an inability to target and acetylate nucleosomal 
histones (Candau et al., 1997). It has also been observed through structural studies that the 
SANT domain of Ada2 physically limits the Gcn5 Lys223 side chain from interacting with the 
Coenzyme A phosphate group (Sun et al., 2018). By virtue of these interactions, total deletion 
of Gcn5 or the Ada2-interacting domain will affect total histone acetyltransferase activity in the 
cell. 
 
5.2 RNA-seq  
There are many conclusions and observations one can infer about the genome from exploring 
the genomic DNA alone, however, transcriptome analysis offers a higher-resolution snapshot 
into the function of the genome. With the power of employing RNA-seq, that is, the 
Next-Generation sequencing technology that lends to understand genomic RNA populations in 
the cell in a high-throughput manner, researchers are now equipped to ask deeper questions 
about the spatio-temporal consequences of gene regulation.  
 
Definition 
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 RNA-seq allows for one to identify and quantify the type and amount of RNA in cell at any given 
moment, genetic background or experimental condition. The most popular application of 
RNA-seq is to explore differential gene expression in a cell after mutation or experimental 
treatment--comparing Wildtype to Experimental Condition (mutant, treatment, time-point). 
This information is valuable in creating a more holistic understanding of the gene regulatory 
landscape as the cell is constantly responding to the changing dynamics of the internal or 
external cellular environment. With RNA-seq, researchers can ask questions about different 
species of RNA in the cell--total RNA, ribosomal RNA, small RNA, microRNA, nuclear RNA, etc. 
The protocol is straightforward as it generally consists of RNA isolation, RNA selection or 
depletion and cDNA synthesis. RNA-seq can also be employed to understand RNA splicing, as 
exon, intron and exon-intron boundaries can be identified and analyzed in RNA-seq datasets.  
 
Gcn5 relevant applications 
There are many studies exploring the role of Gcn5 in basic and biomedical biology through 
identification of gene targets, expression profiling and co-regulation. As Gcn5 is a well studied 
transcriptional co-activator, these studies span widely across organisms and vary deeply in the 
questions prioritized. Here, I will focus on a few examples of the relevant applications of 
RNA-seq in exploring the role of Gcn5 in gene regulation. 
 
The advent of RNA-seq provided new avenues for investigating how Gcn5 can affect gene 
expression and gene regulation upon external stimuli, over time or via mutation. For example, 
expression profiling through high-throughput RNA-seq demonstrated that Gcn5 regulates FGF 
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 signaling and activates selective Myc target genes during early embryoid body differentiation 
(Wang et al., 2017). Furthermore, RNA-seq has been employed to explore the role of ​GCN5 ​in 
alternative splicing that contributes to cellular reprogramming and pluripotency in mice. 
Through an RNAi screen, Hirsch and colleagues uncovered a co-regulatory network between 
Gcn5 and Myc which positively affects expression of an essential alternative splicing regulatory 
network during somatic cell reprogramming (Hirsch et al., 2015). 
 
Over the years, Gcn5 has been shown to have crucial yet specific functions in various cellular 
physiologies (stress response, ribosomal protein gene regulation, pluripotency, histone 
acetylation and non-histone protein acetylation). RNA-seq allows researchers to dig deeper into 
how these functions are reflected in differential gene expression and by using the appropriate 
mutants it is possible to identify targets that are directly or indirectly regulated by Gcn5.  
 
 
Additionally, as Gcn5 is an enzymatic protein, further questions regarding how the catalytically 
active or inactive state of Gcn5 affects gene expression in categories of genes and across the 
genome. In tandem with differential gene expression analysis, RNA-seq of samples mutated 
with Gcn5 (be it through point mutation, loss-of-function, over-expression or 
dosage-dependent mutation), pre-mRNA splicing can be surveyed as well. This information 
provides a more holistic understanding of the role of Gcn5 in gene regulation. 
 
5.3 Chromatin Immunoprecipitation Sequencing (ChIP-seq) 
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 Chromatin Immunoprecipitation (ChIP) is the molecular biology technique whereby proteins are 
cross-linked to DNA and immunoprecipitated to identify these proteins’ genetic targets as well 
as relative enrichment at particular genomic loci. Combined with Next-Generation Sequencing, 
ChIP-seq brings a birds eye view of the abundance of particular protein or chromatin mark 
across the genome. This tool is powerful as it can uncover genome-wide regulation of 
transcription factors, chromatin modifiers, histone modifications as well as general proteins in a 
spatio-temporal context in any genetic or biochemical background. For example, assay provided 
key insights and confirmation into the mechanisms that regulate gene expression throughout 
stages in development via the ENCODE (Encyclopedia of DNA Elements) project (The ENCode 
Project Consortium, 2004). 
 
Definition 
ChIP-seq follows the same protocol of classic ChIP experimental set-up as the enrichment of loci 
bound by the protein of interest is the measurable outcome. Standard ChIP involves 
crosslinking total DNA to protein by a formaldehyde treatment followed by glycine to quench 
the reaction and prevent over-crosslinking. The DNA-protein complexes are then subjected to 
sonication to shear the DNA components into fragmented lengths optimized for accurate 
detection of the complex. Magnetic beads attached to the antibody of interest are added to the 
mixture of protein-bound DNA complexes to isolate the protein of interest. After 
immunoprecipitation and various cycles of high-/low-salt washing, the only complexes that 
remain should contain the protein of interest. The cross-links are reversed and the DNA is 
purified--leaving the DNA fragments enriched for the protein of interest. In ChIP-seq, these 
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 fragments are sequenced then mapped to the genome and quantified based on signal to input. 
The resulting data uncovers a base-by-base resolution of enrichment for a protein or 
chromatin-associated mark of interest across the genome assayed. 
 
Gcn5 relevant applications 
Given the physical role of Gcn5 in gene activation and histone acetylation, ChIP-seq 
experiments provide a fantastic opportunity to understand the physical relationship of Gcn5 to 
the genome in various genetic and biochemical contexts. Many groups have employed ChIP-seq 
in various studies of Gcn5 occupancy, however, I will specifically focus on two examples. In 
HeLA cells, Gong and colleagues found that Gcn5 (along with Usp22) is bound to intergenic and 
intronic regions across the genome, but with few in the promoter region. They also found that 
Gcn5 can function in a diverse array of metabolic physiological processes in HeLA cells per the 
Gene Ontology (GO) analysis of the ChIP-seq data. The Usp22 and Gcn5 binding sites had similar 
distributions across the whole genome. Further analysis showed that the majority of Usp22 
binding sites were located within intronic and intergenic regions, and approximately 58% of the 
peaks were located in intergenic, 34% in introns, 5% in exons and 3% in the promoter. For Gcn5 
51% of the binding sites were in intergenic, 40% in introns, 5% in exons and 4% in the promoter 
(Gong et al., 2018). This result may challenge previous observations that Gcn5 is predominantly 
found at the promoter regions of protein coding genes, however, given the transient and 
quick-turnover nature of Gcn5 in acetylating histone residues, this data may rather reflect 
nuances in the dynamics of binding rather than static profiles of binding at these genetic 
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 sequences. Potentially, increased binding for Gcn5 at the intronic regions of genes can suggest 
a more direct role for Gcn5 regulation at the level of the intron. 
 
As mentioned earlier, cooperation between Gcn5-HAT, the SWI/SNF complex and the 
chaperone Ydj1 was uncovered primarily through ChIP-seq analyses with a variety of mutants. 
ChIP of histone H3 across the genome revealed that in ​GCN5​ depleted cells, histone H3 eviction 
was more defective compared to the other mutants. Deletion of gcn5 results in impaired H3 
eviction upstream of the promoter at select Sulfurometron Methyl (SM)-induced groups of 
genes in the yeast genome. Per the report, the H3 histone at the -1 nucleosome remains at the 
promoter of these stress-induced genes much longer than in WT cells. The results of these 
analyses supported that that SWI/SNF, Gcn5, and Ydj1 cooperatively evict promoter 
nucleosomes and that through this mechanism, the most highly expressed genes in the yeast 
genome are most greatly affected by loss of any of these factors.  
 
Bruzzone et al. employed a large genome-wide analysis using multiple NGS techniques to 
identify patterns of histone acetylation and Mediator deployment across the yeast 
protein-coding genome. Instead of drug-induced stress response or genetic depletion, Bruzzone 
and colleagues used the Anchor Away technique to deplete nuclear Gcn5 and ChIP-seq to 
survey RNA polymerase II association across the genome. They found that this depletion leads 
to a modestly decreased recruitment of RNAPII to nearly all yeast genes, with a moderate bias 
towards SAGA-dominated genes (Bruzzone et al., 2018). With the context of earlier studies 
showing Gcn5 having a modest effect on gene expression (with the exception of stress 
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 conditions), these analyses may suggest other more complex roles for Gcn5 functioning in gene 
regulation. 
 
One of the primary strengths of ChIP-seq is the ability to map DNA-protein interactions across 
the genome in any genetic or biochemical background. This information opens a wealth of 
understanding into the complexities of Gcn5 across the genome--from structure to function. 
Mapping chromatin-associated factors (such as histone modifications) provides a more 
complete picture for where and how Gcn5 is targeting its histone acetyltransferase activity. 
 
Limitations 
One of the primary weaknesses of using ChIP-seq is its inability to directly address questions 
involving RNA-protein interactions--particularly regarding pre-mRNA. Although many indirect 
insights can be and have been gathered using ChIP-seq (Gunderson and Johnson, 2009; 
Gunderson et al., 2011), the argument in the field remains on the premise that ChIP-seq assays 
DNA-protein interactions directly and not RNA-protein interactions. The general assumption is 
that the since DNA region(s) of interest will directly produce the pre-mRNA in question upon 
transcription, the co-transcriptional nature of spliceosomal assembly kinetics should tightly 
mirror what proteins bind to the associated DNA. General limitations of ChIP-seq revolve 
around optimizing experimental conditions which can affect the reproducibility of experimental 
data. Method of sonication (manual or automated) can affect the efficiency and yield of 
sonicated chromatin which can underestimate the number of DNA-protein interactions 
quantified in downstream analyses. Specificity as well as fidelity of antibodies used can cloud 
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 the true representation of interaction--i.e. using elongating versus initiating RNAPII antibodies 
to assess polII occupancy across genes. Additionally, limitations of ChIP-seq can be seen in the 
interpretation of data where protein association with a genomic sequence does not explicitly 
define a direct functional relationship at the locus. Due to the forced nature of protein 
crosslinking early in the experimental prep, an overrepresentation of proteins in the vicinity of 
the locus can be confounded with proteins actually functioning on the locus in question. 
 
5.4 Micrococcal Nuclease Sequencing (MNase-seq) 
WIth most of the genome being punctuated by the structural nucleosomal particles that 
precede or respond to gene regulatory dynamics, it has become increasingly important to 
understand the localization of these nucleosomes through experimental conditions. MNase-seq 
follows roughly similar principles as ChIP-seq as the micrococcal nuclease is used to digest DNA 
that is not associated with nucleosomes, regions of the genome that are more or less sensitive 
to the treatment are sequenced then mapped and quantified based on signal to input ratio. 
MNase is often used to explore nucleosome localization, stability, and genomic structure in 
response to a genetic mutation, biochemical treatment or environmental change.  
 
Definition 
Micrococcal nuclease is an endo-/exo-nuclease enzyme used to digest DNA that is not 
associated with nucleosomes. In an MNase-seq experiment, MNase is added to cells at a 
particular concentration to introduce single-stranded followed by double-stranded breaks in 
DNA that is not associated with nucleosomes, and the reaction is halted with EDTA. 
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 Nucleosome-associated DNA is insensitive to MNase (Axel, 1975; Sulkowski and Laskowski, 
1962) and as such, the exonuclease property of MNase continues to digest DNA molecules until 
it reaches a nucleosome that is protected by DNA. The resulting undigested DNA-nucleosome 
particles are then sequenced and mapped to the genome--providing key information about the 
location of nucleosomes. 
 
Gcn5 relevant applications 
Bruzzone and colleagues were interested in exploring patterns of histone acetyltransferase and 
Mediator association at protein coding genes in yeast and chose to employ various NGS 
techniques to uncover key insights. In addition to other NGS techniques, MNase-seq was used 
in this paper to further explore the role of Gcn5 in transcription. The group found that nuclear 
depletion by anchor-away of Gcn5 did not affect nucleosome occupancy when surveying the 
top 500 genes that showed a >30% reduction in RNAPII under Gcn5 depletion (Bruzzone et al., 
2018).  
 
Strengths 
One of the primary strengths of MNase-seq is in its ability to map nucleosomes across the 
genome. Prior to this, proxies for nucleosome localization were often left to ChIP-seq on 
nucleosome-associated proteins. Another strength is its ability to cover a lengthy spectrum of 
regulatory protein locations and binding sites in the genome as nucleosomes function as a 
major platform for gene regulatory activity. With regards to Gcn5, this aids in understanding 
more nuanced roles for Gcn5 in nucleosomal gene regulation. 
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Limitations 
While MNase-seq offers a unique look into the regulatory landscape of Gcn5 with regards to 
nucleosome positioning, the identity of the regulatory elements that may span the 
MNase-sensitive region remains unknown in these types of datasets. As a consequence, 
MNase-seq data must be paired with ChIP-seq data in order to make sense of the regulatory 
landscape--for example, coupling enrichment of differentially modified H3 provide insight to 
the nature of the nucleosome at the position denoted by MNase-seq. Additionally, older studies 
have noted that the sequence-specificity of MNase enzyme can introduce bias into 
MNase-derived datasets (Horz and Altenburger, 1981; Flick et al., 1986; Noll and Kornberg, 
1977). Lastly, incomplete digestion by MNase in the wet-bench phase of the experimental prep 
can be an issue when quantifying results during the data analysis stage--under-estimating the 
true results. 
 
6.1 Rationale for genome-wide exploration of Gcn5 in splicing 
The Johnson lab has shown that Gcn5-dependent histone acetylation affects co-transcriptional 
spliceosome assembly and splicing efficiency of two intron-containing genes, however it was 
not known how the enzyme affects splicing on a genome-wide scale. A proper survey of the 
global co-transcriptional splicing landscape under depletion of Gcn5 and its major histone 
target is necessary. Understanding the role of Gcn5-dependent histone acetylation in 
co-transcriptional splicing across the genome can provide broader yet more refined 
implications for its function in integrating chromatin dynamics with pre-mRNA splicing. For 
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 example, does Gcn5 affect splicing efficiency of all intron-containing genes in the same 
manner? Are there particular structural or functional categories of genes that are more 
sensitive to Gcn5 depletion? Next-generation based sequencing data can provide suggestive 
mechanistic information for Gcn5 in splicing that is contextualized by the dynamic nature of 
chromatin and co-transcriptional splicing in the cell. For example, are there other processes in 
the gene regulatory program that may influence how Gcn5 is affecting co-transcriptional 
splicing? Are highly expressed intron-containing genes affected differently than lowly expressed 
genes? The structural and functional identity of the genes that are categorically affected by 
these mutations can provide deeper and more critical insights into how Gcn5-dependent 
histone acetylation influences co-transcriptional splicing genome-wide and this thesis aims to 
explore that. In Chapter 2, I explore the genome-wide role of ​GCN5​ in pre-mRNA splicing 
through RNA-seq (a first for the field) and in Chapter 3, I provide evidence for the role of 
chromatin architecture determining Gcn5-dependent splicing outcomes as a putative 
mechanism. Lastly, in Chapter 4, I summarize the major findings of the data and offer future 
directions to future researchers directly or indirectly interested in investigating this topic 
collaboratively. 
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CHAPTER 2 - Loss of Gcn5-mediated histone acetylation demonstrates categorical effects on 
regulation of gene expression and splicing genome-wide 
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 2.1 Introduction 
In Eukaryotes, pre-mRNA splicing occurs in a co-transcriptional manner. As RNA Polymerase II 
transcribes nascent RNA molecules, the spliceosome sequentially assembles onto these 
pre-mRNA transcripts simultaneously. There are vast implications for the chromatin 
environment playing a role in facilitating co-transcriptional splicing, as RNAPII is heavily 
influenced by dynamics in the chromatin environment. Events such as chromatin remodeling, 
nucleosome positioning and post-translational modification of histones have been shown to 
influence splicing in both yeast and mammals. 
 
The step-wise assembly of the spliceosome onto pre-mRNA occurs co-transcriptionally, while 
the nascent transcript is synthesized from RNA Polymerase II. The mechanisms underlying the 
molecular coupling and coordination of these co-transcriptional reactions have not been 
thoroughly elucidated in the context of the dynamic chromatin environment. The Johnson Lab 
previously discovered that the major yeast histone acetyltransferase (HAT) Gcn5 demonstrates 
genetic interactions with ​MSL1​ and ​LEA1​—two core U2 small nuclear ribonucleoprotein particle 
(snRNP) components of the spliceosome. Additionally, they observed that Gcn5 HAT activity is 
required for proper co-transcriptional recruitment of the spliceosome in yeast where U2 snRNP 
association with the pre-mRNA and subsequent spliceosomal rearrangements are sensitive to 
Gcn5-dependent histone acetylation. Gcn5-dependent histone acetylation is enriched at the 
promoter, but the HAT was surprisingly found throughout the intron-containing genes, ​DBP2 
and ​ECM33​. Deletion of histone deacetylases (HDACs) ​HOS2​ and ​HOS3​ revealed H3K9 and 
H3K14 acetylation throughout the gene bodies and abnormal persistence of U2 snRNP factors 
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 near the branch-point region of the pre-mRNA—with aberrant recruitment of downstream 
splicing factors. While Gcn5-dependent acetylation is important for the fate of spliceosomal 
rearrangements, the genome-wide implications and overall mechanism underlying this result is 
not yet clear. 
 
Ribosomal protein genes (RPGs) represent the most abundant subset of intron-containIng 
genes in any given yeast cell. In a vegetative cell, the pre-mRNA molecules synthesized from 
RPGs comprise approximately ninety percent of splicing substrates (Ares, 1999; Lopez and 
Seraphin, 1999; Warner, 1999). In yeast, exit from a proliferative state to entry into meiosis can 
function as a response to environmental circumstances that call for differentiation of gene 
expression programs that will reduce ploidy and increase survival (Esposito and Klapholz, 1981; 
Mitchell, 1988). This transition typically occurs in response to nutrient (such as nitrogen) 
deplete conditions. The gene expression program governing early meiotic genes responds to 
and is activated by this nutrient sensitivity and activates a major transcriptional reprogramming 
event--namely, global repression of RPG transcription (Mitchell et al., 2010; Juneau et al., 
2007). Additionally, the efficiency of pre-mRNA specific to the meiotic gene expression program 
increases the efficiency of splicing during this stage (Juneau et al., 2007; Munding et al., 2013). 
After the RPGs are repressed in early meiosis, they are subsequently induced during late 
meiosis, even while starvation conditions persist (Chu et al., 1998; Munding et al., 2010; Primig 
et al., 2000). 
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 Munding et al discovered that competition between pre-mRNA substrates for limited 
spliceosomes in the cell contributes to the splicing regulation--particularly in responses to 
meiosis and cellular stress. Due to the highly abundant and intron-rich nature of the RPGs in 
yeast, during vegetative growth, spliceosomes are disproportionately titrated away from the 
remainder of the pre-mRNA pool. Splicing of these transcripts is therefore not as efficient as 
overall splicing is buffered by the limited availability of spliceosomes. At the onset of meiosis, 
RPG expression decreases, and global splicing efficiency (including splicing of meiotic 
transcripts) increases as a result of competition for the limited spliceosomes being relieved. 
 
Here, I show that although Gcn5 is a general transcriptional regulator, it facilitates varied 
effects on the genome in regards to splicing and expression. These effects have been 
categorized and with deeper analysis, I found that multiple layers of regulation underlie these 
multiple outcomes of the loss of ​GCN5​ in the ​S. cerevisiae​ genome.  
 
2.2 Materials and methods 
 
Strains and Culture Conditions 
All yeast strains used in this study were derived from BY4741 and are listed in the table below. 
Wildtype, ​gcn5Δ​ and ​H3Δ9-16​ yeast strains were grown on solid YPD agar plates and colonies 
were inoculated into two separate flasks of liquid media per strain (two (2) biological 
replicates). Each strain was grown to mid-log phase at 30 degrees Celsius in 30mL YPD media 
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 (1% yeast extract, 2% peptone, 2% dextrose) and 10mL was collected via centrifugation for RNA 
isolation and RNA-seq library prep.  
Strain Name Description Source 
WT BY4741 This study 
gcn5Δ his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MATa This study 
H3Δ9-16 MATa ​his3Δ200 leu2Δ0 lys2Δ0 trp1Δ63 ura3Δ0 met15Δ0 
can1::MFA1pr-HIS3 hht1-hhf1::NatMX4 hht2-hhf2::[HHTS-HHFS]*-URA3 plus 
pJP11 plasmid [CEN LYS HHF1-HHT1] 
GE Dharmacon 
 
RNA Isolation and RNA-seq Library Preparation 
RNA was isolated via hot phenol:chloroform:isoamyl alcohol (PCA) extraction with SDS as 
described in Ares, 2012 from each biological replicate. Ethanol precipitation at -20 degrees 
Celsius was performed to precipitate the RNA and concentration was quantified with a 
NanoDrop 2000 spectrophotometer (ThermoFisher). A total of 20 μg of RNA was treated with 
DNase I (Roche) and depleted of rRNA with the Ribo-Zero Gold rRNA Removal Kit (Illumina) for 
each of the 6 RNA samples. 
 
RNA-seq library preparation was performed as described per the Illumina TrueSeq RNA Library 
Prep Kit v2 protocol. Multiplexed RNA libraries were generated with two (2) biological 
replicates for each genetic strain (Wildtype, ​gcn5Δ​ and ​H3Δ9-16​)--totaling 6 samples. Final 
library preparation of each sample was 10nM of 260bp cDNA fragments, as quantified by Qubit. 
100 base pair single-end reads were generated on Illumina HiSeq 4000. Sequencing depth was 
45948517 and 46236120 for each lane sequenced. Reads were aligned to the SacCer3 genome 
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 assembly using the STAR alignment package (​http://code.google.com/p/rna-star/​). Genes with 
less than 5 RPKM in the average of WT conditions were filtered out. 
 
Splicing Efficiency Calculation 
Splicing efficiency is calculated via the following ratio equation: [spliced counts]/([spliced 
counts] + [unspliced raw counts]) where “spliced counts” represents the number of aligned 
reads flanking exon-exon boundaries of an intron-containing gene and “unspliced counts” 
represents the number of aligned reads flanking intron-exon, intron-only and exon-intron 
regions of the same intron-containing gene. The reads in each category are normalized by 
functional length to account for the number of possible alignments per category. Genes with 
less than 5 unspliced raw counts in WT were filtered out. 
 
Quantification and Statistical Analysis 
Original RNA-seq data represented in all graphs and plots represent the average of 2 biological 
replicates. For RNA-seq analysis, Spearman’s correlation for non-parametric test was used to 
compute the p-values between the noted x and y data. Error bars in the bar graphs represent 
the standard error of the mean (SEM). Associated P-values were determined by Mann-Whitney 
test/one-way ANOVA as stated per figure legend. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, 
p ≤ 0.0001. Statistical analyses were performed in Microsoft Excel (Version 15.28) and Prism 8 
(GraphPad).  
 
Data Visualization 
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 Original RNA-seq data was represented in bar graphs while Venn Diagrams and scatter plots 
were produced in Prism 8 (GraphPad).  
 
2.3 Results 
GCN5 and its major histone target residues are required for proper RNA expression of 
intron-containing transcripts genome-wide 
RNA-seq was employed to understand how expression and splicing are affected by Gcn5 or its 
major histone targets globally. Upon ​gcn5Δ ​and ​H3Δ9-16​, global average RNA expression 
level was not affected (Fig. 1A). I predicted that these mutants would not affect global average 
RNA expression as previous literature echoes Gcn5’s lack of effect on transcriptional output. To 
explore whether groups of genes are affected by either mutant in a single direction, the RPKM 
for all protein coding genes in either wildtype or mutant (filtering parameters: ≥5 RPKM in WT) 
were plotted on a scatter plot (Fig. 1B and Fig. 1C).  
 
Here, I found that the intron containing class of genes (ICGs) display distinct features in gene 
expression in response to Gcn5-histone acetyltransferase mutants. To explore whether the 
RPKM levels of ICGs are behaving the same as all genes, I plotted the average RNA expression 
level for WT, ​gcn5Δ ​and ​H3Δ9-16 ​(Fig. 1D and Fig. 1E)​.​ Surprisingly, I found that 
Gcn5-mediated histone acetylation decreases the average expression of ICGs as a functional 
group (Fig. 1G). To determine if the wildtype expression level of these ICGs is a determinant of 
how Gcn5-mediated histone acetylation affects RNA expression changes, I grouped all ICGs into 
quintiles based on WT expression level and plotted these against the change in RPKM level in 
53 
 the mutant background (Fig. 1F).  Gcn5-mediated histone acetylation decreases the average 
expression of highly expressed ICGs. Additionally, most of the lowly expressed ICGs are 
benefiting from both ​gcn5Δ​ and ​H3Δ9-16​, while the highly expressed ICGs are decreasing. 
SInce the spread of these highly expressed ICGs (in regards to change in RPKM level) clump 
together in a distinct manner, there may be a strong relationship between WT expression level 
and effect on transcription for these intron containing genes. 
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FIGURE 1 (A-D): Gcn5 and its major histone target residues are required for RNA expression of intron containing 
transcripts -​ A) Bar graph representing the average RPKM level of all genes (n = 5534 genes) for each strain 
determined by RPKM values across two biological replicates. SEM is calculated and represented as error bars. B-C) 
Each scatterplot represents the average mutant RPKM level (y-axis) relative to average WT RPKM level (x-axis). 
Values represent average across two biological replicates and yellow line represents x=y. Each black dot represents 
a single non-ICG while red dots in B) are ICGs in ​gcn5Δ​ and green dots in C) are ICGs in​ H3Δ9-16​ (p < 0.0001). D) 
Bar graph representing the average RPKM level of ICGs (n = 264) for each strain determined by RPKM values across 
two biological replicates. SEM is calculated and represented as error bars. 
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FIGURE 1 (E-G): Gcn5 and its major histone target residues are required for RNA expression of intron containing 
transcripts -​ E) Bar graph representing the average RPKM level of all non-ICGs (n = 5273, p < 0.01) for each strain 
determined by RPKM values across two biological replicates. SEM is calculated and represented as error bars. F) 
Fold change in average mutant RPKM level of ICGs (for both mutants) ranked by average WT RPKM level. ICGs 
were ranked by WT RPKM level from lowest to highest and categorized into 5 bins of n = 46 genes each. Y-axis 
represents log​2​(ΔRPKM) for mutant RPKM relative to WT RPKM for each gene. G) Plot of fold change mutant 
RPKM level relative to WT for all genes (n = 5534, p < 0.0001), non-ICGs (n = 5273, p < 0.0001) and ICGs (n = 264, 
ns) for each mutant. 
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 Expression of intron-containing-RPGs (IC-RPGs) decreases in response to Gcn5 and H3 
mutation while expression of IC-non-RPGs are both increasing and decreasing. 
RIbosomal protein genes comprise the largest functional class of intron-containing genes in 
yeast (Fig. 2A). They also are the most highly expressed and well-spliced group of genes. To 
determine if all ribosomal protein genes are decreasing in expression, I plotted expression 
changes based on IC-non-RPGs and IC-RPGs categories. Deletion of ​GCN5​ and the locus 
harboring the major histone targets of Gcn5p (​H3Δ9-16​) resulted in the decreased expression 
of all intron-containing RPGs (IC-RPGs), while non-RPGs are increasing and decreasing in 
expression (Fig. 2B). Although this result is striking, the extent of relative down-regulation 
between ​gcn5Δ​ and the ​H3Δ9-16​ mutant on RPG expression is not surprising, as Gcn5p 
directly regulates the promoters of RPGs and is still present in the H3 mutant. I also explored 
the overlap of IC-non-RPGs with similar RNA expression changes between ​gcn5Δ​ and 
H3Δ9-16​ mutant and found that there is no bias in the overlap towards any direction 
(increasing or decreasing), and no shared functional group in these genes (Fig. 2C and Fig. 2D).  
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FIGURE 2: Deletion of ​GCN5​ and its major histone target residues decrease RNA expression of all intron 
containing ribosomal protein genes -​ A) Pie-chart representing total number of ​S. cerevisiae​ intron containing 
genes with percentage of ribosomal protein genes (RPGs) and non-RPGs. B) Plot representing fold-change in 
average mutant RPKM level relative to average WT RPKM for IC non-RPGs and IC-RPGs for each mutant strain. C) 
Venn Diagram of IC-non-RPGs increasing in average mutant RPKM compared to average WT RPKM between 
mutants (n = 81). D) Venn Diagram of IC-non-RPGs decreasing in average mutant RPKM compared to average WT 
RPKM between mutants (n = 85). 
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 RPG expression changes under gcn5Δ​ and ​H3Δ9-16 mutation are not solely due to changes 
in the expression of RPG transcriptional regulators 
In order to understand how ​gcn5Δ​ and ​H3Δ9-16​ was functioning in RPG regulation in my data 
set, it was important to note how the primary factors of RPG regulation were affected by 
experimental conditions. In RPG regulation, Gcn5 acts to acetylate RP-transactivator, Ifh1 which 
negatively regulates RPG expression, followed by deacetylation by sirtuins, Sir2 and Hst1 
(Downey et al., 2013). If Gcn5-HAT activity was directly responsible for the decrease in RPG 
expression, the primary factors of RPG expression would be down-regulated under both 
mutants. ​IFH1​, is down-regulated in the ​GCN5 ​mutant and up-regulated in the H3 mutant (Fig. 
3A). Other regulators of RP gene expression are unaffected in the mutants. 
 
Both ​FHL1​ and ​RAP1​ are decreasing in the ​gcn5Δ ​mutant while increasing and decreasing in 
the ​H3Δ9-16​, respectively (Fig. 3A). Knight et al., 2014 reported that Hmo1 is another regulator 
of RPG expression, and in the RNA-seq dataset, RPKM levels of ​HMO1​ are decreasing in the 
gcn5Δ​ mutant and increasing in the H3 mutant [data not shown]. Hmo1 is described to toggle 
the +1 nucleosome from a repressive to active position to regulate RPGs (Reja et al., 2015). Hst1 
and Sir2 are the primary deacetylases that deacetylate Ifh1 protein in response to Gcn5 
acetylation of RP-promoter-bound Ifh1 and these are both down-regulated in ​GCN5​ mutants 
only and slightly up-regulated in H3 (Fig. 3B).​ ​Other Gcn5 non-histone targets (​RSC4​ and ​CSC6​) 
are decreasing in transcription in ​GCN5​ mutants but not other mutants (​CSC6​ is upregulated in 
the H3) [data not shown].  
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FIGURE 3: RPG expression changes under ​gcn5Δ​ and ​H3Δ9-16​ mutation are not solely due to changes in the 
expression of RPG transcriptional regulators -​ A-C) Fold change in average mutant RPKM level of RPG 
transcriptional regulators (​IFH1, FLH1, RAP1 ​and ​HMO1​), RPG transactivator deacetylases (​HST1 ​and ​SIR2​) and CURI 
complex components (​RRP7, UTP22, CKB2 ​ and ​IFH1​) in both mutants, respectively. Y-axis represents log​2​(ΔRPKM) 
for mutant RPKM relative to WT RPKM for each gene. 
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 Acetylated Ifh1 functions to limit RPG expression in the cell and this modified form of the 
protein is often found accumulated in the CURI complex (consisting of Rrp7, Utp22 and Ckb2) 
which functions to link rRNA processing to RPG transcription (Downey et al., 2013; Rudra et al., 
2007). In order to rule out the role of ​gcn5Δ​ and ​H3Δ9-16​ in modulating RPG expression, I 
analyzed the expression of CURI complex components (Fig. 3C). Surprisingly, all components of 
the complex were down-regulated in the absence of ​GCN5​, while the H3 mutant 
down-regulated expression of 3 out of the 4 components. The lack of consensus on RPG factor 
down-regulation between Gcn5 and lysines 9-16 on H3 suggests that the activity of Gcn5 in 
histone acetylation is not  directly responsible for the overall decrease in RPG expression and 
other mechanisms may be facilitating this effect. 
 
My data however supports that ​GCN5 ​is required to keep RPGs transcribing at a normal level. 
The primary histone target region of Gcn5 (Lysines 9 and 14 within the residues 9-16 on the 
N-terminal tail of Histone H3) is also needed to maintain the normal transcription level of RPGs, 
even though Gcn5p is still present (which negates the confounding role of Gcn5 in directly 
acetylating Ifh1--which binds to RPG promoters and negatively regulates their transcription 
(Downey et al., 2013)). An important consideration to keep in mind is that this result is likely 
not due to a direct relationship between Gcn5-HAT activity and RPGs, as functional redundancy 
between TFIID and SAGA co-binding at RPG promoters may be also contributing to this 
regulation (Huisinga et al., 2004; Lee et al., 2000; Grant and Pugh, 2007). 
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 Ribosomal protein genes are greatly subject to regulation by the TOR kinase pathway, which is 
one of the major pathways of regulating sensitivity to nutrient availability in yeast. In 
vegetatitve conditions, the TOR kinase promotes the recruitment of Ifh1, one of the major RPG 
transactivators, to RPG promoters, where it then interacts with the constitutively 
promoter-bound RPG transcription factor, Fhl1 and in turn activates expression of RPGs (Martin 
et al., 2004; Schawalder, 2004; Wade, 2004; Rudra, 2005). Ifh1 recruitment to RPG promoters is 
essential for RPG expression under tight regulation under nutrient starvation conditions (Martin 
et al., 2004; Schawalder, 2004; Wade, 2004; Rudra, 2005). Gcn5p is known to acetylate this key 
RPG transcriptional activator at RPG promoters, which negatively regulates this gene expression 
program (Downey et al, 2013). Due to the co-regulatory role of Gcn5p in global histone 
acetylation and acetylation of Ifh1, I am interested in understanding the expression of RPGs in a 
GCN5​ and ​H3​ mutant background in order to separate the different modes of regulation by this 
HAT and further understand how Gcn5-mediated acetylation may affect pre-mRNA splicing.  
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Figure 4 (A-E): ​GCN5​ and its major histone target residues function in maintaining proper Splicing Efficiency (SE) 
of ICGs genome-wide​ - ​A) Schematic of % splicing efficiency calculation (% Splicing Efficiency = [spliced 
RNA]/[spliced RNA + unspliced RNA]). B)​ ​Plot representing percent difference in Splicing Efficiency (SE) for filtered 
intron-containing genes under ​gcn5Δ​ relative to wildtype. Splicing efficiencies were averaged between two 
biological replicates for wildtype and mutant and the difference between mutant and wildtype is represented on 
the graph. Dashed line represents +/- %5 difference ([mutant] - [wildtype]) in SE relative to wildtype (n = 232 
genes, spliced/unspliced read count ≥5 in WT and ​mutant​). C)​ ​Plot representing percent difference in Splicing 
Efficiency (SE) for filtered intron-containing genes under ​H3Δ9-16 ​relative to wildtype. Splicing efficiencies were 
averaged between two biological replicates for wildtype and mutant and the difference between mutant and 
wildtype is represented on the graph. Dashed line represents +/- %5 difference ([mutant] - [wildtype]) in SE 
relative to wildtype (n = 232 genes)​ ​D)​ ​Venn diagram representing the overlap of ICGs that constitute <5% 
decrease in SE in ​gcn5Δ ​and ​H3Δ9-16 ​compared to wildtype. The numbers shown indicate the number of ICGs 
represented by each mutant after filtering.​ ​E)​ ​Venn diagram representing the overlap of ICGs that constitute >5% 
increase in SE in ​gcn5Δ ​and ​H3Δ9-16 ​compared to wildtype. The numbers shown indicate the number of ICGs 
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 represented by each 
(cont’d)     ​Figure 4 (cont’d) 
(F-G):​ mutant after filtering. 
F)​ ​Scatter Plot representing 
fold change in SE for ​gcn5Δ 
relative to wildtype versus 
wildtype gene expression 
for all ICGs after filtering (n 
= 232). Intron-containing 
Ribosomal Protein Genes 
(RPGs) are highlighted in red 
and non-RPGs are 
highlighted in black. X-axis is 
represented as wildtype 
gene expression in RPKM 
and y-axis is the Log(base2) 
transformation of the ratio 
between SE in ​gcn5Δ​ and 
wildtype. G)​ ​Scatter Plot 
representing fold change in 
SE for ​H3Δ9-16 ​relative to 
wildtype versus wildtype 
gene expression for all ICGs 
after filtering (n = 232). 
Intron-containing Ribosomal 
Protein Genes (RPGs) are 
highlighted in red and 
non-RPGs are highlighted in 
green. X-axis is represented 
as wildtype gene expression 
in RPKM and y-axis is the 
Log(base2) transformation 
of the ratio between SE in 
H3Δ9-16​ and wildtype. 
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 Surprisingly, there is a high overlap between genes that are decreasing in splicing efficiency as 
well as increasing in splicing efficiency between ​GCN5​ and the H3 mutant, suggesting that the 
splicing outcomes of these genes is directly influenced by ​gcn5Δ​ and ​H3Δ9-16​ (Fig. 4D and 
4E). Given the overall decreased RPG expression shared in both ​gcn5Δ​ and ​H3Δ9-16​ as well as 
the lack of relationship between change in splicing and WT RNA expression outcomes (Fig. 4F 
and 4G), this high overlap between ​gcn5Δ​ and ​H3Δ9-16​ amongst IC-non-RPGs improving in SE 
presents intriguing support for the RPG effect occurring in a ​gcn5Δ​ and ​H3Δ9-16​ context. This 
observation is also consistent with other reports regarding the RPG effect (Awad et al., 2017). 
However, the IC-non-RPGs that are decreasing in SE have yet to be explained by any previously 
reported mechanism or shared functionality, particularly as there is no enrichment for any 
particular GO term. The above figures show that there is surprisingly a lack of consensus on the 
effect of splicing in a single direction for both mutants (Fig. 4A and 4B). Additionally, there lacks 
a strong relationship between the change in splicing efficiency and level of wild-type gene 
expression for ICGs as a whole (Fig. 4F and 4G), however, there may be a relationship between 
functional categories (i.e. RPGs and non-RPGs) and consequences of Gcn5-dependent 
co-transcriptional splicing. So far, it may be predicted that both mutants would lead to a 
decrease in co-transcriptional splicing overall given their critical function in transcriptional 
regulation as well as the results from the previous work in the lab showing aberration of 
splicing factors on intron containing genes under similar mutations.  
 
Given the surprisingly polarized result, there may be a functional and perhaps regulatory 
mechanism which is establishing the balance between improved and defective splicing 
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 efficiency. One possibility could be a shift or dysregulation of the total abundance of splicing 
factors in each mutant cell. Previous work showed that deletion of Gcn5 and perturbation of 
histone acetyltransferase dynamics resulted in a reduced physical recruitment of two major U2 
snRNP components to the branchpoint-adjacent region of two intron-containing genes 
(Gunderson and Johnson, 2009; Gunderson et al., 2011). I then sought to analyze the 
expression of splicing factors under each condition. 
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Figure 5: ​GCN5 ​and the H3 lysine 9-16 residues are necessary for maintaining normal RNA expression of splicing 
factors​ - ​A)​ ​Plot representing fold change in average RPKM for each mutants​ ​relative to wildtype for all splicing 
factors after filtering (n = 103; RPKM ≥5 counts in WT and ​mutant​). List of splicing factor genes was generated from 
the Saccharomyces Genome Database (SGD) Gene Ontology search term for ‘RNA splicing’ (GO:0008380). Each 
gene encoding a splicing factor is represented as ​gcn5Δ​ highlighted in red and ​H3Δ9-16​ are highlighted in green. 
Y-axis is the Log(base2) transformation of the ratio of change in average RPKM level between either ​gcn5Δ 
(P-value < 0.0001) or ​H3Δ9-16​ (P-value < 0.0001) and wildtype. B) Gene ontology enrichment of splicing factors 
decreasing in mutant average RPKM relative to average WT RPKM in both mutants. C)​ ​Venn diagram representing 
the overlap of splicing factor genes that constitute any decrease in RPKM level in ​gcn5Δ ​and ​H3Δ9-16 ​compared 
to wildtype. The numbers shown indicate the number of splicing factor genes represented by each mutant.​ ​D) 
Gene ontology enrichment of splicing factors increasing in mutant average RPKM relative to average WT RPKM in 
both mutants. E) Venn diagram representing the overlap of splicing factor genes that constitute any increase in 
RPKM level in ​gcn5Δ ​and ​H3Δ9-16 ​compared to wildtype. The numbers shown indicate the number of splicing 
factor genes represented by each mutant. 
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 The Venn Diagrams above revealed that 17 splicing factor genes were up-regulated in RPKM 
expression under both ​gcn5Δ ​and ​H3Δ9-16​ compared to 32 genes down-regulated in both 
mutants (Fig. 5C and 5E). I performed Gene Ontology annotation on this group of overlapped 
factors to determine if there is a consensus to the step in splicing for which these up- and 
down-regulation events represent. Interestingly, the highest number of splicing factors 
down-regulated in both ​gcn5Δ​ and ​H3Δ9-16 ​are associated with the U4/U6-U5 tri-snRNP 
complex (17/32 genes)--seconded by the U2 complex (13/32 genes) (Fig. 5B). I found this result 
intriguing as Gunderson et al, 2011 observed that histone deacetylation is necessary for 
recruitment of snRNPs downstream of U2. Additionally, as GO analysis presents there to be 34 
genes annotated with this complex in SGD, over 50% of the splicing factors down-regulated 
between ​gcn5Δ​ and ​H3Δ9-16​ mutants are represented here. Amongst the U2 complex genes 
down-regulated between ​gcn5Δ​ and ​H3Δ9-16​ mutants was ​MSL1​, another gene implicated in 
the earlier studies with Gcn5p and splicing (Gunderson and Johnson, 2009). 
 
The same analysis as above was performed for the 17 splicing factors sharing up-regulation in 
expression for both mutants (Fig. 5E) and the component with the largest shared annotation 
was the U2-type spliceosome complex (9/17 genes) with U2-type pre-spliceosome factors being 
the more specific annotation (5/17 genes) (Fig. 5D). Combining these two results, an interesting 
case seems to be further supported for the role of ​gcn5Δ​ and ​H3Δ9-16​ in spliceosome 
assembly as the factors that are upregulated sequentially precede the immediate step in 
assembly for which the factors that are down-regulated represent. This data suggests that 
gcn5Δ​ and ​H3Δ9-16​ (be it direct or indirect) may be primarily functioning during the 
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 transition between U2 snRNP assembly, disassembly and tri-snRNP assembly. The 
pre-spliceosome complex is implicated in the association of the 5' SS with U1, while the BPS is 
recognized by the U2 snRNP, prior to the pre-catalytic spliceosome (Will & Luhrmann, 2011). 
 
Expression of intron-containing RPGs (IC-RPGs) decreases in response to Gcn5-HAT mutation 
and splicing efficiency of non-RPGs are bidirectionally affected 
The result of ​IFH1​ down-regulation being associated with overall decreased RPG gene 
expression is consistent with data from the Ares group (Munding et al., 2013). This group also 
presented a new model for understanding the limited nature of the spliceosomes in the cell. 
During normal conditions, the RPGs make up the largest and most efficiently spliced functional 
class of introns in the cell--making them the primary target of spliceosomes while non-RPGs are 
left to compete for the remaining pool of spliceosome (Munding et al., 2013). In conditions 
where RPG expression is decreased (nutrient starvation, meiosis, etc), these spliceosomes are 
“freed up” from the missing RPG transcripts and left to benefit the splicing of non-RPG 
introns--thus increasing splicing efficiency of this group of genes (Munding et al., 2013). Given 
the overall decrease of RPG transcripts in my dataset, I was interested to observe if this 
synergistic RPG effect was being reproduced in my dataset. Given that upon RPG 
down-regulation, the splicing efficiency of IC-non-RPGs should benefit from the newly available 
pool spliceosomes (Munding et al., 2013), I predicted that all IC-non-RPGs should demonstrate 
increased splicing efficiencies in both the ​gcn5Δ​ and ​H3Δ9-16. ​Surprisingly, the IC-non-RPGs 
demonstrated both increased and decreased splicing efficiencies in each mutant, suggesting 
that there is a subset of IC-non-RPGs that are not as sensitive to this RPG effect (Fig. 6A). The 
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 effect of transcription did not have an effect on splicing efficiency for IC-RPGs and IC-non-RPGs 
under either mutant (Fig. 6B-6E). The non-parametric Mann-Whitney test was used to describe 
the significant difference between the median of IC-RPGs and IC-non-RPGs for each mutant 
without assuming Gaussian/normal distribution while 2-way ANOVA was used to compare the 
difference in the combined means of IC-RPGs and IC-non-RPGs between each mutant. 
Wilcoxon-signed-rank test was used to determine the significance of whether the median SE is 
greater or lesser than 0 for each subcolumn (IC-RPGs and IC-non-RPGs).  
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Figure 6: Expression of intron-containing RPGs (IC-RPGs) 
decreases in response to Gcn5-HAT mutation and 
splicing efficiency of non-RPGs are bidirectionally 
affected​ - ​A) Fold change of average mutant splicing 
efficiency relative to WT. ​NOG2​ and ​NHP6B​ were 
removed as outliers; 2-way ANOVA test was performed 
between ​gcn5Δ​ and ​H3Δ9-16​ and overall, 
Mann-Whitney test was performed between sub-columns 
of each mutant (IC-RPGs (n = 103) vs IC-non-RPGs (n = 127) 
for each mutant and Wilcoxon-signed-rank test was 
performed for each subcolumn (IC-RPGs and IC-non-RPGs) 
for each mutant. B-E) Fold change in average mutant 
RPKM level relative to average WT RPKM level  compared 
to fold change of average mutant splicing efficiency 
compared to WT. Y-axis represents log​2​(ΔRPKM) for 
mutant RPKM relative to WT RPKM for each gene whereas 
x-axis represents log​2​(ΔSplicing Efficiency). The red dots 
in B) and C) represent individual IC-RPGs (n = 103) in 
H3Δ9-16 ​and ​gcn5Δ​, respectively whereas in black dots 
in D) and E) represent individual IC-non-RPGs (n = 127) in ​gcn5Δ​ and ​H3Δ9-16​, respectively. 
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 2.4 Discussion 
Upon beginning this project, the Johnson lab established that acetylation by the transcriptional 
coactivator Gcn5 plays a novel role in co-transcriptional spliceosome assembly (Gunderson et 
al., 2009) and that dynamic histone acetylation is critical for cotranscriptional spliceosome 
assembly and spliceosomal rearrangements (Gunderson and Johnson, 2011). This data 
unearthed new ground for understanding the role of chromatin in splicing and fostered new 
frontiers in this corner of the field. However, the primary gap in knowledge was with regards to 
the role of Gcn5 in splicing genome-wide. Here, I demonstrated that Gcn5-HAT activity 
down-regulates RPG expression which increases the availability of limited spliceosomes to 
improve splicing of a subset of non-RPGs genome-wide. 
 
The results with the histone H3 mutant (​H3Δ9-16​) is most intriguing because according to the 
literature, Gcn5 has a non-histone target that specifically regulates gene regulation of RPGs. In 
the histone mutant, Gcn5 is free to function in this context (of acetylating Ifh1, which places a 
“control brake” on aberrant transcription of RPGs in normal contexts, and helps to 
control/titrate transcription in a nutrient-depleted/stress context) which should predictably not 
hamper the expression of RPGs. The observation that RPGs are all decreasing in transcription in 
the histone mutant when Gcn5 is still present to regulate the non-histone target at RPG 
promoters suggests that acetylation of Histone H3 by Gcn5 is required for RPG expression. 
There seems to be a role for Gcn5-mediated histone acetylation in positively regulating gene 
expression of RPGs specifically, as non-RPGs are both increasing and decreasing in expression in 
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 the H3 and Gcn5 mutant. When Gcn5 is removed, the RPKM of all IC-RPGs (with the exception 
of 1-2) are decreasing. 
 
This work has established a new conceptual framework to consider while exploring questions 
regarding co-transcriptional splicing mechanisms in yeast as well as general, non-yeast splicing. 
This data begins to address a systems-level view of how splicing regulatory networks can be 
interconnected with other gene regulatory processes. Additionally, it proposes an intriguing 
mechanism by which the cell responds to stress. Coordinating RPG expression with splicing 
outcomes may be a way of tuning the cells energy in response to the shift in the gene 
expression needs of the cell. This finding is of particular importance to this dissertation thesis 
work as Gcn5 is implicated in RPG regulation at the level of chromatin structure and 
transcription (Downey et al., 2013). Taking into account the competitive strategy described 
above is crucial to gaining proper conceptual understanding of the biological consequences of 
Gcn5 in splicing. I aimed to use the findings above as fundamental considerations to guide the 
experiments in order to understand the effect of Gcn5-dependent acetylation on splicing 
outcomes--separate from its co-regulatory role in RPG expression--and through the context of 
stress regulation. 
 
The loss of Gcn5 affects Ifh1 regulation of Ribosomal Protein Genes and seems to compound 
the with the effect of Gcn5 in gene activation via histone acetylation, leading to a ~50% loss of 
RPKMs in this functional class relative to wildtype. The loss of Lysines 9 through 16 on Histone 
H3 may contribute to the decreased ability for the RPGs to activate. In addition to 
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 Gcn5-non-histone effects, these RPG may be highly sensitive to ​gcn5Δ​ and ​H3Δ9-16​ as their 
promoter architecture commands labile nucleosomes (Knight et al., 2014) and available HAT 
activity to keep transcription at normal levels. 
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CHAPTER 3 - The role of Gcn5 in connecting chromatin architecture to splicing of non-RPGs, 
genome-wide 
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 3.1 Introduction 
Nucleosomes are 147bp of DNA wrapped around a histone octamer with 2 copies of H2A, H2B, 
H3 and H4. Packaging of genomic DNA into chromatin regulates access of proteins that activate 
gene expression, DNA replication, recombination and repair. Biochemical modification of the 
histones regulate the state of the chromatin which dictates transcriptional activity. For 
example, hyper-acetylated chromatin facilitates a transcriptionally active region while 
hypo-acetylated chromatin does the opposite (a repressed chromatin state). Acetylation of 
histone H3 and H4 tends to peak at promoters and as thus, Gcn5 and Esa1, two histone 
acetyltransferases are often found at transcriptionally active promoters (Pokholok et al., 2005; 
Robert et al., 2004). 
 
Chromatin is the principal template for transcription regulation and it is well-established that 
the organization of these DNA-protein complexes have vast implications for the physical and 
kinetic regulation of genes and transcriptional output across the genome. For example, intricate 
higher order folding of chromatin into Topologically-Associated Domains (TADs) and other 
looping structures facilitate physical long-range genome interactions between regulatory 
elements in mammalian cells to enhance or suppress gene expression (Dixon et al., 2012). 
Post-translational modifications (such as monoubiquitination) of histone proteins within 
chromatin influence the rate of transcription ​in vitro ​(Pavri et al., 2005). Given the spatially 
complex yet systematic nature of transcriptional activation, elongation and termination, 
abundant opportunities for coordinated regulation can occur between chromatin, transcription 
and other gene regulatory compartments, such as pre-mRNA splicing.  
80 
  
Pre-mRNA splicing of intron-containing genes (ICGs) occurs by stepwise assembly of the large 
multi-subunit ribonucleoprotein spliceosome complex onto specific splice site sequences in the 
intron. This stepwise process of spliceosome assembly onto pre-mRNA occurs 
co-transcriptionally. While the nascent RNA protrudes from the RNA Pol II exit tunnel during 
transcription, the spliceosome begins assembling on the transcript almost immediately as the 
intron is transcribed (Oesterreich et al., 2016). Approximately 40nt from the 5’ end of the 
nascent RNA is the minimum distance required to initiate assembly of the catalytic spliceosome 
during Step I recognition of the branchpoint sequence in budding yeast (Liu and Cheng, 2012). 
Considering that the average rate of transcription elongation of budding yeast protein-coding 
genes is approximately 1.5kb/minute with the full splicing reaction being completed in just 
under 5 seconds, deciphering the functional and spatio-temporal relationship between 
spliceosome assembly and the transcriptional environment is of active investigation in the field 
(Mason & Struhl, 2005; Oesterreich et al., 2016). Given the added dynamicity of the chromatin 
environment regulating transcription, the relationship between splicing and chromatin is of 
particular interest. 
 
Recently, there has been a growing appreciation of the various models for the relationship 
between chromatin and splicing. Direct models tend to describe physical recruitment 
mechanisms between chromatin factors and spliceosome assembly as well as the kinetic 
relationship between transcription elongation rate and spliceosome assembly. On the other 
hand, indirect models, such as the shifting competition of spliceosomes in response to changes 
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 in ribosomal protein gene expression, can affect global splicing outcomes. It is well understood 
that Gcn5 impacts nucleosomal dynamics and chromatin accessibility and that this can 
influence transcription. The Johnson lab has shown that chromatin modifiers make unique 
contributions to pre-mRNA splicing through these direct and indirect models (Leung et al., 
2019; Neves et al., 2017; Awad et al., 2017). The data presented in Chapter 2 is the first 
genome-wide investigation of Gcn5-HAT activity in pre-mRNA splicing and these results suggest 
an indirect model of regulating splicing outcomes. In particular, the observation of decreased 
RPG expression followed by increased splicing efficiency of a subset of non-RPGs brings the 
indirect model of ribosomal protein gene (RPG) regulation into a global splicing context. 
 
One of the ways that splicing of ICGs can be broadly affected is through the availability of 
spliceosomes in the cell. Ares and colleagues mechanistically demonstrated that spliceosomes 
represent a limited cellular resource and by virtue, are subject to competition by an array of 
ICGs (Munding et al., 2013). Given that RPGs represent the largest, most transcript-abundant 
and most efficiently spliced class of ICGs in the cell, these tend to have a large competitive 
advantage for sequestering most of the limited spliceosomes in the cell. Non-RPGs are thus left 
with the remainder of this pool of spliceosomes which sensitizes their splicing outcomes to the 
fate of RPG expression. In the event that RPG expression decreases, the competition for the 
limited spliceosomes is relinquished, and non-RPG splicing efficiency benefits. Decreased RPG 
expression leads to an increase in splicing efficiency due to the increased availability of 
spliceosomes. The RNA-seq data presented in Chapter 2 demonstrates the consequential 
relationship between ​gcn5Δ​ and ​H3Δ9-16​, RPG regulation and pre-mRNA splicing in a 
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 genome-wide context. Following the well-established model reported above, in a Gcn5-HAT 
deficient background, all intron-containing non-RPGs are predicted to benefit from the 
increased availability of spliceosomes with an increased splicing efficiency.  
 
Surprisingly, a subset of non-RPGs from the RNA-seq data within this model show a decreased 
splicing efficiency despite the increased availability of spliceosomes. This group of genes may be 
governed by a separate layer of gene regulation that impacts splicing outcomes. Given the role 
of Gcn5 in post-translational modification of the chromatin landscape, I hypothesized that there 
may be a link between chromatin architecture and splicing outcomes at these genes. 
Potentially, distinct variability in the chromatin accessibility landscape of this group of genes 
may mediate a lack of sensitivity to the RPG effect. Given the comprehensive evidence 
implicating the role of chromatin architecture in spliceosome assembly and splicing outcomes 
(Leung et al., 2019; Matveeva et al., 2019; Henriques et al., 2013; Jimeno-Gonzalez et al., 2015; 
Andersson et al., 2009; Tilgner et al., 2009; Schwartz et al., 2009; Kolasinska-Zwierz et al., 2009; 
Jonkers et al., 2014), this hypothesized chromatin landscape variability may facilitate kinetic or 
physical regulatory processes which desensitize the genes to regulation by the RPG effect. The 
purpose of this chapter is to identify and characterize this group of genes in order to 
understand the functional significance for why they lack sensitivity to this RPG effect. 
 
Is there a linear relationship between how much a gene is expressed and if this affects the 
chromatin landscape in the presence or absence of Gcn5? I predicted that the more expressed 
a gene is, the less nucleosomes that stably occupy that particular gene locus. There may be a 
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 strong relationship between H3 occupancy and expression. The primary question here is 
whether there is a connection between this observation and splicing outcomes. I initially sought 
to understand if splicing outcomes of a gene can be predicted from the landscape of the 
chromatin environment of the gene. This understanding can be sought from analyzing 
meta-gene sequencing profiles which describe the enrichment of a few key chromatin marks 
describing the nature of the loci. 
 
My first approach is to explore the chromatin state of different categories of genes--each 
category defined by the unique effect of ​gcn5Δ​ and ​H3Δ9-16 ​on splicing of introns in those 
categories from Chapter 2. If there is a relationship between the chromatin state of a gene and 
the effect that ​gcn5Δ​ and ​H3Δ9-16​ has on its splicing, then this supports a direct role for 
Gcn5-mediated HAT activity in genome-wide splicing. 
 
3.2 Materials and Methods 
 
Strains and Culture Conditions 
All yeast strains used in this study were derived from BY4741 and are listed in the table below. 
Wildtype, ​gcn5Δ​ and ​H3Δ9-16​ yeast strains were grown on solid YPD agar plates and colonies 
were inoculated into two separate flasks of liquid media per strain (two (2) biological 
replicates). Each strain was grown to mid-log phase at 30 degrees Celsius in 30mL YPD media 
(1% yeast extract, 2% peptone, 2% dextrose) and 10mL was collected via centrifugation for RNA 
isolation and RNA-seq library prep.  
84 
  
Strain Name Description Source 
WT BY4741 This study 
gcn5Δ his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 MATa This study 
H3Δ9-16 MATa ​his3Δ200 leu2Δ0 lys2Δ0 trp1Δ63 ura3Δ0 met15Δ0 
can1::MFA1pr-HIS3 hht1-hhf1::NatMX4 hht2-hhf2::[HHTS-HHFS]*-URA3 plus 
pJP11 plasmid [CEN LYS HHF1-HHT1] 
GE Dharmacon 
 
RNA Isolation and RNA-seq Library Preparation 
RNA was isolated via hot phenol:chloroform:isoamyl alcohol (PCA) extraction with SDS as 
described in Ares, 2012 from each biological replicate. Ethanol precipitation at -20 degrees 
Celsius was performed to precipitate the RNA and concentration was quantified with a 
NanoDrop 2000 spectrophotometer (ThermoFisher). A total of 20 μg of RNA was treated with 
DNase I (Roche) and depleted of rRNA with the Ribo-Zero Gold rRNA Removal Kit (Illumina) for 
each of the 6 RNA samples. 
 
RNA-seq library preparation was performed as described per the Illumina TrueSeq RNA Library 
Prep Kit v2 protocol. Multiplexed RNA libraries were generated with two (2) biological 
replicates for each genetic strain (Wildtype, ​gcn5Δ​ and ​H3Δ9-16​)--totaling 6 samples. Final 
library preparation of each sample was 10nM of 260bp cDNA fragments, as quantified by Qubit. 
100 base pair single-end reads were generated on Illumina HiSeq 4000. Sequencing depth was 
45948517 and 46236120 for each lane sequenced. Reads were aligned to the SacCer3 genome 
assembly using the STAR alignment package (​http://code.google.com/p/rna-star/​). 
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Splicing Efficiency Calculation 
Splicing efficiency is calculated via the following ratio equation: [spliced counts]/([spliced 
counts] + [unspliced raw counts]) where “spliced counts” represents the number of aligned 
reads flanking exon-exon boundaries of an intron-containing gene and “unspliced counts” 
represents the number of aligned reads flanking intron-exon, intron-only and exon-intron 
regions of the same intron-containing gene. The reads in each category are normalized by 
functional length to account for the number of possible alignments per category. 
 
Quantification and Statistical Analysis 
Original RNA-seq data represented in all graphs and plots represent the average of 2 biological 
replicates. For RNA-seq analysis, Spearman’s correlation for non-parametric test was used to 
compute the p-values between the noted x and y data. Error bars in the bar graphs represent 
the standard error of the mean (SEM). Associated P-values were determined by Mann-Whitney 
test/one-way ANOVA as stated per figure legend. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, 
p ≤ 0.0001. Statistical analyses were performed in Microsoft Excel (Version 15.28) and Prism 8 
(GraphPad).  
 
Public Datasets 
The datasets used for meta-gene analysis of Gcn5-AA ChIP-seq (RNAPII-Ser5p, histone H3, 
H3K9ac) and MNase-seq were derived from Bruzzone et al., 2018. The data files were 
downloaded publically from the Gene Expression Omnibus under accession series GSE109235 
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 and represent the average of three biological replicates each. Antibodies used for experimental 
design are as follows: RNAPII-Ser5p (Abcam ab5131), histone H3 (Abcam ab1791) and H3K9ac 
(Millipore 07-392) 
 
Data Visualization 
Original RNA-seq data represented in bar graphs, Venn Diagrams and scatter plots were 
produced in Prism 8 (GraphPad). For meta-gene analysis, all plots were visualized in SeqPlots 
interactive software (Version 3.10; Stempor and Ahringer, 2014). 
 
Meta-gene Analysis 
All meta-gene analysis was performed by SeqPlots interactive software to determine the 
average pattern distribution and density of chromatin signatures across genomic loci. The 
custom BED files used to categorize non-RPGs were generated via the UCSC Table Browser 
(Karolchik et al., 2004). For ‘SE up’, all filtered non-RPGs (total = 129 genes) with an average 
increase in splicing efficiency under both ​gcn5Δ​ and ​H3Δ9-16 ​(total = 45 genes) were 
compiled in one custom BED file with all associated genomic regions of interest. The same 
process was performed for ‘SE down’, where a total of 44 genes were compiled into a seperate 
BED file. WIG files with the average occupancy ratio of associated ChIP-seq and MNase-seq data 
were downloaded from publically available genomic datasets (as described above). Plots 
analyzed average occupancy ratio for all marks annotated in the corresponding figures and 
centered on the transcription start site (TSS), with the range of -500bp to +1200bp. 
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3.3 Results 
Wildtype RNA expression level and splicing efficiency does not determine Gcn5-HAT 
dependent splicing outcomes of IC-non-RPGs  
Gcn5-mediated acetylation is increased on highly expressed genes to facilitate chromatin 
accessibility for transcription (Xue-Franzen et al., 2015). Given the co-transcriptional nature of 
splicing, I aimed to identify the WT transcription level of IC-non-RPGs that are either increasing 
or decreasing in both ​GCN5​ and H3 mutants. If the splicing outcomes of IC-non-RPGs show a 
distinguishable association to wildtype RNA expression level, then this may suggest the role of 
RNA expression in sensitizing genes to the RPG effect. Although the data in Chapter 2 
demonstrated that there is no relationship between the Gcn5-dependent change in RNA 
expression level and change in splicing efficiencies for these IC-non-ICGs, the WT level of RNA 
expression of these IC-non-ICGs may be associated with the splicing outcome under ​gcn5Δ​ and 
H3Δ9-16​ mutation. There is a lacking relationship between WT expression level and 
Gcn5-dependent splicing outcomes (Fig. 1A-D). My next question was to determine if there is a 
relationship between WT splicing efficiency of these non-RPGs genes and change in splicing 
efficiency. Are more poorly spliced non-RPGs likely to be decreasing in splicing efficiency? Upon 
repeating the same analysis for wildtype splicing efficiency and Gcn5-dependent splicing 
outcomes, there was also a lack of correlation Fig. 1E. The same analysis was repeated for 
genes with greater than 5% change in splicing efficiency to rule out potential noise of minimal 
effects on splicing Fig. 1F​. ​To rule out the possibility of any shared function in the non-RPGs 
decreasing in splicing efficiency, I performed a Venn Diagram analysis to identify genes with 
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 overlapping effects in Gcn5-HAT mutant background (Fig. 1G) followed by a GO analysis. There 
were no significant GO terms from component, process or function ontology with p-value cutoff 
of 0.05 that was found for the non-RPGs decreasing in SE under both ​gcn5Δ​ and ​H3Δ9-16 
[data not shown]. This data suggests that the Gcn5-dependent effects on non-RPG splicing 
outcomes are not determined by a shared cellular function, the associated wildtype RNA 
expression level or capacity for efficient splicing efficiency.  
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Figure 1 (A-D) - Wildtype RNA expression level and splicing efficiency does not determine Gcn5-HAT dependent 
splicing outcomes of IC-non-RPGs: ​A-B) Plot representing fold change in average RPKM for each IC-non-RPG 
compared to wildtype RPKM level based on A) decreasing splicing efficiency (SE) under mutants or B) increasing 
splicing efficiency under mutants. Mutant RPKM relative to wildtype RPKM after filtering (n = 127 total; spliced and 
unspliced read count ≥5 in WT). Each dot represents an IC-non-RPG represented as ​gcn5Δ​ highlighted in red and 
H3Δ9-16​ are highlighted in green. Y-axis is the Log​2​ transformation of the ratio of change in average RPKM level 
between either ​gcn5Δ ​(P-value < 0.01) or ​H3Δ9-16​ (P-value < 0.01) and wildtype and x-axis is average WT RPKM 
level. C-D) Average WT RPKM level for C) filtered IC-non-RPGs with any decreased SE (n = 42) or increased SE (n = 
44) under both mutants and D) filtered IC-non-RPGs with ≥5% decrease (n = 14) or increase (n = 15) in SE under 
both mutants. Error bars represent SEM of two biological replicate measurements of WT RPKM.  
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Figure 1 (E-G) - Wildtype RNA expression level and splicing efficiency does not determine Gcn5-HAT dependent 
splicing outcomes of IC-non-RPGs: ​E-F) Plot representing average % WT Splicing Efficiency for E) all filtered 
IC-non-RPGs with either any decreased SE (n = 44) or any increased SE (n = 45) under both mutants and F) all 
filtered IC-non-RPGs with ≥5% decrease (n = 14) or increase (n = 15) in SE under both mutants. Error bars represent 
SEM of two biological replicates. G) Venn Diagram representing IC-non-RPGs decreasing in SE compared to WT 
with at least ≥5% decrease in SE for each mutant.  
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 gcn5Δ​ and ​H3Δ9-16 dependent splicing outcomes of IC-non-RPGs are associated with 
distinct differences in RNAPII and H3K9ac profiles 
Characterizing chromatin architecture at genes is important for understanding the complex 
coordination of transcription and chromatin dynamics (Boeger et al., 2003; Carey et al., 2006; 
Carrozza et al., 2005; Henikoff, 2016; Joshi and Struhl, 2005). Given the co-transcriptional 
nature of splicing and since WT RNA expression level, splicing efficiency and shared cellular 
function have not determined ​gcn5Δ​ and ​H3Δ9-16​-dependent splicing outcomes of 
IC-non-RPGs, I aimed to observe if there are inherent differences in the structure of chromatin 
at these groups of genes. If there are differences in the chromatin environment profiles 
correlated with ​gcn5Δ​ and ​H3Δ9-16​ dependent splicing outcomes, there may be a supporting 
evidence for the direct role of ​gcn5Δ​ and ​H3Δ9-16 ​activity in co-transcriptional splicing.  
 
To explore the contribution of chromatin structure to Gcn5-dependent splicing outcomes, I 
analyzed multiple ChIP-seq and MNase-seq datasets from Bruzzone et al. 2018 that assayed for 
the enrichment or recruitment of RNAPII, H3, H3K9ac and MNase sensitivity in a Gcn5+/- 
background (via rapamycin induced anchor-away method). My protocol was to categorize all of 
the non-RPGs by whether they decrease or increase in splicing efficiency in the ​gcn5Δ​ and 
H3Δ9-16 ​mutants (overall and by at least 5% in my RNA-seq dataset), then analyze the average 
enrichment profile for each category via the chromatin signatures mentioned above. If there 
were differences in the enrichment profile of any particular category based on whether they 
decrease or increase in Gcn5-dependent splicing, then the chromatin landscape plays a role in 
determining splicing outcomes in a ​gcn5Δ​ and ​H3Δ9-16​ dependent context. Additionally, 
92 
 consensus patterns between multiple chromatin signatures for any category of genes may hint 
at a pattern that validates biological significance of the categories (i.e. if one category shares 
both increased average RNAPII and increased average H3K9ac in similar loci, this may implicate 
increased chromatin accessibility for the category, on average). This data would begin to 
elucidate if the chromatin environment of non-RPGs decreasing in splicing efficiency under 
gcn5Δ​ and ​H3Δ9-16 ​is the distinguishing reason for why they seem to be less sensitive to the 
RPG effect. 
 
First, I analyzed the average recruitment profile of RNAPII for each category of genes. If the 
genes that are decreasing in splicing efficiency under deletion of ​GCN5​ have a reduced 
abundance of RNAPII at their loci, this may implicate a shared pattern of the binding state of 
RNAPII. Non-RPGs with decreased splicing efficiency (“SE down”) contain on average an 
increased occupancy of RNAPII at the transcription start site (TSS) when compared to the 
non-RPGs increasing in splicing efficiency (“SE up”) (Fig. 2A). This result is also observed in 
genes with greater than 5% change in splicing efficiency (Fig. 2B). Additionally, the occupancy 
profile of RNAPII downstream of the TSS varies distinctly between both categories--where 
non-RPGs decreasing in splicing efficiency demonstrate a steadily decreasing occupancy relative 
to the TSS and those that are increasing maintain a consistent level of occupancy throughout 
the gene. This data also demonstrates a decline and recovery of RNAPII near what seems to be 
the intronic region of the gene locus for those non-RPGs that are increasing in splicing 
efficiency. The same is not seen for the SE down category. Since RNAPII-Ser5p (the elongating 
form of post-translationally modified RNA Polymerase II) was immunoprecipitated in this 
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 ChIP-seq experiment, this result has strengthened implications for the state of the enzyme at 
these loci. The elongating RNAPII at the non-RPGs decreasing in splicing efficiency may be losing 
affinity for the template DNA as transcription progresses--potentially hinting at physical 
chromatin barriers to processivity for this group of genes that are not as present for SE up. 
Another potential hypothesis for this result can be associated with each category of genes 
expressing differences in average elongation rate given that the average WT RNA transcript 
levels are consistent between categories. There may also be differences in the stalled/paused 
state of RNAPII between these categories. Without further experiments, it will be difficult to 
resolve the explicit state and rate of the RNAPII elongation complex in these categories of genes 
from occupancy and distribution alone. 
 
To determine if ​gcn5Δ​ and ​H3Δ9-16 ​mutation has a different degree of effect on the change 
in RNA expression level based on its splicing outcome in non-RPGs, I pooled the average fold 
change in RPKM level under both ​GCN5​ and the H3 mutant based on splicing outcome (>5% 
change) in ​gcn5Δ​ and ​H3Δ9-16​ mutation (Fig. 2C). I found that non-RPGs increasing in splicing 
efficiency under ​gcn5Δ​ and ​H3Δ9-16​, tend to be increasing in RNA expression in both mutants 
as well. The non-RPGs decreasing in SE did not share this pattern in change, suggesting the 
functional state of RNAPII at these genes may be distinct from those in SE up. Collectively, this 
data reports an association between ​gcn5Δ​ and ​H3Δ9-16 ​dependent splicing outcomes of 
non-RPGs and the locus-wide binding pattern of elongating RNAPII that is not due to WT RNA 
transcript level.  
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Figure 2 (A-E) - ​gcn5Δ​ and ​H3Δ9-16 ​dependent splicing 
outcomes of IC-non-RPGs are associated with distinct 
differences in RNAPII and H3K9ac enrichment profiles: 
A-B) Meta-gene plot representing average enrichment 
profile of RNAPII-Ser5p for A) all filtered IC-non-RPGs either decreasing (n = 44, blue) or increasing (n = 45, red) in 
splicing efficiency by any amount and B) all filtered IC-non-RPGs with ≥5% decrease (n = 14) or increase (n = 15) in 
SE under both mutants. Y-axis represents the average enrichment per locus while x-axis represents the distance 
from the TSS. C) Plot representing fold change in average RPKM for each mutant relative to wildtype for non-RPGs 
either decreasing (n = 14) or increasing (n = 15) in SE. ​gcn5Δ​ is highlighted in red and ​H3Δ9-16​ i highlighted in 
green. Y-axis is the Log​2​ transformation of the ratio of change in average RPKM level between either ​gcn5Δ​ or 
H3Δ9-16​ and wildtype. D-E) Meta-gene plot representing average enrichment profile of H3K9ac for D) all filtered 
IC-non-RPGs either decreasing (n = 44, blue) or increasing (n = 45, red) in splicing efficiency by any amount and E) 
all filtered IC-non-RPGs with ≥5% decrease (n = 14) or increase (n = 15) in SE under both mutants. Y-axis represents 
the average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Figure 2 (F-G) - ​gcn5Δ​ and ​H3Δ9-16 ​dependent splicing outcomes of IC-non-RPGs are associated with distinct 
differences in RNAPII and H3K9ac enrichment profiles: ​F-G) Meta-gene plot representing average enrichment 
profile of H3 for F) all filtered IC-non-RPGs either decreasing (n = 44, blue) or increasing (n = 45, red) in splicing 
efficiency by any amount and G) all filtered IC-non-RPGs with ≥5% decrease (n = 14) or increase (n = 15) in SE under 
both mutants. Y-axis represents the average enrichment per locus while x-axis represents the distance from the 
TSS. 
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 I next asked whether there were differences in the average H3K9ac profile across the loci 
between each category of genes. The enrichment of H3K9ac does not differ in the main gene 
body based on splicing outcomes (Fig. 2D). However, for non-RPGs decreasing in splicing 
efficiency, there is an increased peak of H3K9ac near the TSS relative to the profile of non-RPGs 
increasing in splicing efficiency (Fig. 2D and 2E). As Gcn5p is the major yeast histone 
acetyltransferase, the enriched TSS-proximal H3K9ac at the non-RPGs decreasing in splicing 
efficiency suggests that this category of genes may be more sensitive to a lack of ​GCN5​ and 
H3K9-16 acetylation activity and that this is sensitivity is potentially resulting in the decreased 
splicing splicing efficiency. This result is intriguing as previous reports have shown that histone 
acetylation by Gcn5 stimulates nucleosome binding and remodeling by the SWI/SNF complex 
(Chandy et al. 2006; Chatterjee et al. 2011). To determine if the increased H3K9ac was a 
product of increased H3 at the loci for these genes, I analyzed H3 enrichment across the gene 
body for both categories. While Gcn5p depletion resulted in decreased H3 across the gene in 
both groups, there was no marked difference in WT abundance of H3 across the gene in either 
group (Fig. 2F and 2G).  
 
gcn5Δ and H3Δ9-16 dependent splicing outcomes of IC-non-RPGs are associated with 
differences in nucleosome positioning 
In recent years, nucleosomes have been implicated in having a role in splicing. For example, 
Chen and colleagues observed higher occupancy of nucleosomes arranged at exonic sequences 
whereas intron sequences displayed lower occupancy in mammals (Chen et al., 2010). To 
determine if there was a difference in the nucleosome occupancy profile of non-RPGs based on 
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 Gcn5-dependent effects on splicing, I plotted MNase-seq distributions for each category (Fig. 3). 
Intriguingly, I found distinct distribution patterns of nucleosome occupancy associated with 
splicing outcomes in Gcn5-HAT mutant background. More specifically, non-RPGs with 
decreasing splicing efficiency demonstrate a well-defined MNase-seq digestion array across the 
gene whereas those that are increasing in splicing efficiency tend to display fuzziness in the 
gene body. Additionally, the height of the nucleosome occupancy peaks are distinct between 
groups. The SE down category of non-RPGs is associated with loci that are strongly sensitive to 
MNase digestion, while the SE up category represents otherwise. Given the chromatin 
implications of MNase sensitivity at gene loci, the different profiles between non-RPGs 
decreasing and increasing in splicing efficiency reflect a difference in the chromatin 
environment associated with Gcn5-dependent splicing outcomes.  
 
For SE down, it appears as though the well-defined MNase-seq digestion signature reflects 
nucleosomes that are more stably associated with the DNA. In contrast, peaks with more 
modest amplitude and less clear dips (as represented by the non-RPGs increasing in splicing 
efficiency) demonstrate a signature associated with more mobile nucleosomes. Given the 
results from Figure 2B, SE up IC-non-RPGs are presumably more active and therefore the 
nucleosomes are more likely to be sliding around relative to genes that are being 
down-regulated which could have more stable nucleosomes. Since metagene plots are an 
average signal distribution over a group of genes, nuanced information about the chromatin 
environment on a single-gene basis may be lost. To hone in on the the individual chromatin 
environment IC-non-RPGs with >5% SE in either direction, I repeated the above analysis on 
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 individual IC-non-RPGs (Supplementary Figures). I also provide representative IGV tracks for 
each gene (Supplementary Figures). Together with the above data, IC-non-RPGs that are 
decreasing in splicing efficiency under Gcn5-dependent splicing may demonstrate a WT 
chromatin environment that is designed for less mobile gene regulatory elements. 
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Figure 3 - ​gcn5Δ ​and​ H3Δ9-16 ​dependent splicing outcomes of IC-non-RPGs are associated with differences in 
nucleosome positioning:​ ​A-B) Meta-gene plot representing average enrichment profile of MNase digestion for A) 
all filtered IC-non-RPGs either decreasing (n = 44, blue) or increasing (n = 45, red) in splicing efficiency by any 
amount and B) all filtered IC-non-RPGs with ≥5% decrease (n = 14) or increase (n = 15) in SE under both mutants. 
Y-axis represents the average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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 DISCUSSION 
My data provides support for the state of chromatin architecture determining Gcn5-dependent 
splicing outcomes for non-RPGs (Fig. 4). This observation also provides support for non-RPGs 
decreasing in ​gcn5Δ​ and ​H3Δ9-16​ dependent splicing being less sensitive to the increased 
availability of spliceosomes due to the RPG effect. The result that ​gcn5Δ​ and ​H3Δ9-16 
dependent splicing outcomes are associated with differences in MNase sensitivity profiles 
raises several mechanistic hypotheses regarding the state of the nucleosome environment and 
its connection to splicing. Potentially, these observations may support the model for ​gcn5Δ 
and ​H3Δ9-16​ function in facilitating direct recruitment of splicing factors to chromatin. Under 
this model, a stable nucleosome landscape provides the opportunity for Gcn5 protein or 
Gcn5-modified lysines on H3 to physically recruit splicing factors. ​gcn5Δ​ and ​H3Δ9-16 ​would 
decrease recruitment of splicing factors to chromatin and result in decreased splicing 
outcomes. Alternatively, the ​gcn5Δ​ and ​H3Δ9-16​ mutation may be influencing transcription 
elongation rate such to sensitize groups of genes with a particular chromatin environment to 
collaborate less effectively with co-transcriptional spliceosome assembly. 
 
Both of these models support a role for ​gcn5Δ​ and ​H3Δ9-16​ dependent activity in pre-mRNA 
splicing genome-wide, within the additional context of the RPG effect on spliceosome 
distribution. The experimental analyses in Chapter 3 were performed to identify why the subset 
of IC-non-RPGs decreasing in SE seem to be less sensitive to the RPG effect. The nature of the 
chromatin landscape, particularly regarding the mobility of nucleosomes, may be involved in 
establishing precursory limitations for co-transcriptional splicing outcomes, despite  
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Figure 4 - Model for the relationship between Gcn5-histone acetyltransferase activity and pre-mRNA splicing 
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 the availability of spliceosomes. Hypothetically speaking, if a chromatin environment contains a 
nucleosome occupancy profile that is less permissive to recruiting splicing factors or facilitating 
an optimized transcription elongation rate, the perceived benefit (for IC-non-RPGs) of an 
increased availability of spliceosomal factors will not not be realized due to the natural barriers 
of the chromatin at these gene loci.  
 
RPGs are known to be the most highly-expressed and transcript abundant class of genes in 
yeast and share a chromatin landscape marked by fragile nucleosomes. For example, fragile 
nucleosomes are defined by multiple parameters such as relative sensitivity to MNase, stability 
and distance between the -1/+1 nucleosome, competitive binding of general transcription 
factors, sequence motifs, etc. RPGs may represent a more transcriptionally plastic class of 
genes--supported by increased nucleosome fragility and aptitude for environmental/nutrient 
stress response and etc. Recent reports implicated the occupancy of the RSC complex, a 
multi-subunit complex that binds to acetylated histones, as an identifier of fragile nucleosomes. 
The Rsc4 protein of the RSC complex is inactivated by Gcn5 acetylation at Lys 25 and as a result, 
Gcn5 demonstrates inhibited binding of its bromodomain to acetylated H3K14 (VanDemark et 
al., 2007). ​gcn5Δ​ and ​H3Δ9-16​ dependent activity may be functioning directly at these fragile 
nucleosomes for IC-RPGs and non-IC-RPGs, thus providing more support for the physical 
recruitment model of spliceosome assembly.  
 
The MNase results are striking yet invite complex interpretations. One of the hypotheses I 
originally aimed to explore was whether IC-non-RPGs with decreased splicing efficiency under 
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 GCN5​ have a MNase-seq profile reflective of nucleosomes that are less likely to be displaced 
which may potentially be more resilient to changes in spliceosome availability. This would be 
further supported if IC-non-RPGs with increased splicing efficiency demonstrate the inverse 
profile. If this group of genes harbor a chromatin environment that is primed for the type of 
regulation that does not require highly mobile regulatory elements or activity, the RPG effect 
induced availability of spliceosomes may meet physical barriers at these loci, specifically. 
Nucleosomes by definition are barriers for transcriptional machinery and can regulate access of 
these factors to the protected DNA template. Per the data I presented in this chapter, the 
IC-non-RPGs with decreased splicing efficiency may be less sensitive the RPG effect given a 
chromatin environment that is either more or less protected (or stabilized) by nucleosomes. 
This implicates a direct physical mechanism for the relationship between Gcn5 and spliceosome 
assembly.  
 
In order to fully elucidate the specific mechanism that is underlying why a subset of non-RPGs 
are less sensitive to the availability of spliceosomes, further experiments are needed. For 
example, if the physical recruitment model is determining splicing outcomes in a ​gcn5Δ​ and 
H3Δ9-16​ dependent manner, identifying the localization of Gcn5 at these genes would be of 
great interest. If Gcn5 is enriched at these genes, it would strongly implicate its role in 
physically recruiting spliceosome components. This data would be strengthened by 
accompanying ChIP-seq of factors associated with sequential spliceosome components (U1 
snRNP, U2 snRNP, prp19, etc). NET-seq in a ​GCN5​ mutant background would also help to 
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 determine average elongation rates for each group of non-RPGs to discriminate between the 
physical and kinetic relationship of ​gcn5Δ​ and ​H3Δ9-16​ to splicing outcomes.  
 
Overall, this scientific body of work presents an unique methodology for understanding the 
varied effects of ​gcn5Δ​ and ​H3Δ9-16​ in pre-mRNA splicing. Prior to this project, the 
genome-wide effects of ​gcn5Δ​ and ​H3Δ9-16​ in splicing were not known and widely accepted 
understanding that Gcn5 does not affect global transcription, it may have been inferred that 
there is no role for ​gcn5Δ​ and ​H3Δ9-16 ​in global splicing outcomes. My data uncovered 
multiple effects of the ​gcn5Δ​ and ​H3Δ9-16​ on pre-mRNA splicing 
genome-wide--encompassing mechanisms regarding the competition of limited spliceosomes 
and distinct chromatin landscapes directly regulating splicing outcomes. Given the highly 
regulated nature of Gcn5 histone acetylation, these results provide intriguing context for the 
collaboration between the chromatin environment and spliceosome assembly. Whether the 
relationship is predominantly governed by a kinetic relationship or a physical relationship will 
be of future interest. Altogether, it can be appreciated that Gcn5 plays a complex role in 
genome-wide pre-mRNA splicing that factors both the economics of spliceosome distribution 
and natural state of the chromatin. 
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Supplementary Figures: 
 
 
 
 
 
Supplementary Figure 1: ​Each meta-gene plot represents the average ChIP-seq enrichment profile of RNAPII-Ser5p 
for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the average 
enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 1 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of 
RNAPII-Ser5p for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents 
the average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 1 (cont’d): ​Each meta-gene plot represents the average ChIP-seq  enrichment profile of 
RNAPII-Ser5p for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents 
the average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 2: ​Each meta-gene plot represents the average ChIP-seq enrichment profile of H3 for 
individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the average 
enrichment per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 2 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of H3 
for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the average 
enrichment per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 2 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of H3 
for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the average 
enrichment per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 3: ​Each meta-gene plot represents the average ChIP-seq enrichment profile of H3K9ac for 
individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the average 
enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 3 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of 
H3K9ac for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the 
average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 3 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of 
H3K9ac for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the 
average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 4: ​Each meta-gene plot represents the average enrichment profile of MNase-seq digestion 
for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the average 
enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 4 (cont’d): ​Each meta-gene plot represents the average enrichment profile of MNase-seq 
digestion for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the 
average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 4 (cont’d): ​Each meta-gene plot represents the average enrichment profile of MNase-seq 
digestion for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both mutants. Y-axis represents the 
average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 5: ​Genome browser tracks showing MNase-seq digestion and ChIP-seq profiles of H3K9ac, 
RNAPII-Ser5p and H3, respectively, for individual IC-non-RPGs demonstrating ≥5% decrease in SE under both 
mutants. Y-axis represents the average enrichment/H3 per locus while gene locus annotations are represented at 
the bottom of each track. 
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Supplementary Figure 5 (cont’d): ​Genome browser tracks showing MNase-seq digestion and ChIP-seq profiles of 
H3K9ac, RNAPII-Ser5p and H3, respectively, for individual IC-non-RPGs demonstrating ≥5% decrease in SE under 
both mutants. Y-axis represents the average enrichment/H3 per locus while gene locus annotations are 
represented at the bottom of each track. 
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Supplementary Figure 6: ​Each meta-gene plot represents the average ChIP-seq enrichment profile of RNAPII-Ser5p 
for individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the average 
enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 6 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of 
RNAPII-Ser5p for individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents 
the average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 6 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of 
RNAPII-Ser5p for individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents 
the average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 7: ​Each meta-gene plot represents the average ChIP-seq enrichment profile of H3 for 
individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the average 
enrichment per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 7 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of H3 
for individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the average 
enrichment per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 7 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of H3 
for individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the average 
enrichment per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 8: ​Each meta-gene plot represents the average ChIP-seq enrichment profile of H3K9ac for 
individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the average 
enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 8 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of 
H3K9ac for individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the 
average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 8 (cont’d): ​Each meta-gene plot represents the average ChIP-seq enrichment profile of 
H3K9ac for individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the 
average enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 9: ​Each meta-gene plot represents the average MNase-seq digestion profile of for individual 
IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the average enrichment/H3 
per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 9 (cont’d): ​Each meta-gene plot represents the average MNase-seq digestion profile of for 
individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the average 
enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 9 (cont’d): ​Each meta-gene plot represents the average MNase-seq digestion profile of for 
individual IC-non-RPGs demonstrating ≥5% increase in SE under both mutants. Y-axis represents the average 
enrichment/H3 per locus while x-axis represents the distance from the TSS. 
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Supplementary Figure 10: ​Genome browser tracks showing MNase-seq digestion and ChIP-seq profiles of H3K9ac, 
RNAPII-Ser5p and H3, respectively, for individual IC-non-RPGs demonstrating ≥5% increase in SE under both 
mutants. Y-axis represents the average enrichment/H3 per locus while gene locus annotations are represented at 
the bottom of each track. 
 
 
 
 
 
 
 
 
132 
  
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 10 (cont’d): ​Genome browser tracks showing MNase-seq digestion and ChIP-seq profiles of 
H3K9ac, RNAPII-Ser5p and H3, respectively, for individual IC-non-RPGs demonstrating ≥5% increase in SE under 
both mutants. Y-axis represents the average enrichment/H3 per locus while gene locus annotations are 
represented at the bottom of each track. 
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CHAPTER 4 - Conclusion and Future Directions 
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 The conversation of how chromatin and pre-mRNA splicing are linked in the cell is widely varied 
and with the advent of Next Generation Sequencing technologies, it has become an excitingly 
complex field to explore. The general question I sought to answer with this doctoral thesis is 
whether or not the major yeast histone acetyltransferase ​GCN5​ plays a genome-wide role in 
pre-mRNA splicing. Here, I show for the first time that deletion of ​GCN5 ​or its major histone 
target region (Lysines 9 through 16 on Histone H3) both resulted in a marked down-regulation 
of intron containing ribosomal protein gene expression (IC-RPGs). Secondly, I showed for the 
first time that both ​GCN5​ and the major histone targets play a role in regulating the efficiency 
of genome-wide splicing outcomes in yeast. The data supporting these major results are 
described in Chapter 2.  
 
In both Chapters 2 and 3, I provide support for two mechanisms that may be governing the 
Gcn5-dependent effects on splicing outcomes genome-wide. Under both mutants studied, 
splicing outcomes both improved and worsened for intron containing genes. To address the 
Gcn5-dependent increases in splicing outcomes, I showed that ​GCN5 ​deletion decreases RPKMs 
of all IC-RPGs, which triggers a redistribution of the limited spliceosomes and thus increased 
splicing to IC-non-RPGs. This mechanism was first elucidated in a non-Gcn5 specific context 
with Munding et al., 2013, and confirmed for the first time for Gcn5 in my RNA-seq data-set. To 
address the ICGs that were decreasing in splicing efficiency and effectively escaping the 
aforementioned “RPG effect”, I used publicly available ChIP-seq and MNase-seq data from 
Bruzzone et al., 2018 to survey the chromatin landscape of these genes (described in Chapter 
3). To date, this was the first time MNase-seq data was used to answer questions about the 
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 chromatin environment and its connection to splicing in a Gcn5 context. I demonstrated that 
ICGs that are either increasing or decreasing in splicing efficiency in a Gcn5-dependent context 
are markedly differentiated by distinct chromatin signatures. In combination, I have opened an 
array of possibilities for mechanisms regarding the genome-wide role of Gcn5 in splicing. 
 
Some of the major strengths of this dissertation research lie squarely the methodological 
approach to uncover novel insights about chromatin and splicing in a Gcn5-dependent context. 
To date, RNA-seq combined with splicing-relevant data analysis methods (i.e. splicing efficiency 
calculations) have not been used to understand the histone acetyltransferase role of Gcn5 in 
splicing.  Additionally, using publically available data is a powerful and efficient approach to 
answering complex questions about gene regulation. As the questions regarding the 
relationship between chromatin and splicing become more sophisticated, the collaborative 
approach of asking new and different questions with the wealth of data that already exists in 
the scientific community can efficiently reduce the cost-benefit ratio of NGS-driven projects. 
For example, the data provided by Bruzzone et al., 2018 was not originally generated for the 
purposes of understanding the relationship between chromatin and splicing. However, I have 
been able to creatively “read-in-between” the lines in my initial observations from Chapter 2, 
generate hypotheses about the categories of genes I am interested in (SE up and SE down in 
Gcn5-dependent context), while imposing the publicly available data as a cost-effective and 
powerful tool to test my hypotheses. With this new approach, I have been able to show that 
there is a particularly unique chromatin environment distinguishing non-RPGs that are 
increasing and non-RPGs are decreasing in Gcn5-dependent splicing efficiency. 
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 The main limitations of this research lie in supplementing the bioinformatics data with classic 
biochemistry experiments as a way to dive deeper into the mechanism. Performing 
Co-Immunoprecipitation experiments in a Gcn5 +/- context between H3K9ac and U2 snRNP 
factors would provide stronger evidence for a direct physical relationship between the 
chromatin template and spliceosome assembly. Additionally, observation of genetic 
interactions between Gcn5, the major histone targets and additional spliceosome components 
can be of support to this mechanism. Another limitation that can be addressed with a future 
direction is to perform NET-seq experiments to explore the role of RNAPII pausing in this 
context. Given the conclusions regarding differences in the chromatin environment per 
Gcn5-dependent splicing outcomes, understanding the nature of RNAPII in a Gcn5 +/- context 
at these gene loci will help to refine the mechanism at play. Additionally, using slow or fast 
RNAPII mutants in combination with ​GCN5​ deletion mutants as a background for the metagene 
analysis can add more nuance to the whether a kinetic mechanism may be a result of the 
chromatin signature differences in these groups of genes. Another area of future opportunity in 
this project would be to add additional Gcn5 and H3 mutants to the array of strains tested. 
Since Gcn5p interacts with other SAGA-complex units, it would be interesting to repeat the 
above experiments in SAGA-complex mutants as well as H4 acetyltransferases to differentiate 
HAT-specific Gcn5 from the influence of SAGA or histone acetyltransferases in general. 
Additionally, since Gcn5 has multiple targets outside of the region focused on in this 
dissertation, it would be of interest to examine point mutants of H3 lysines within the 9-16 
region as well as outside of the region. This would also provide more information about the 
influence of specific residues to facilitating the relationships described in the previous chapters. 
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